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CHAPTER 1 
INTRODUCTION 
Peroral controlled-release multiunit dosage forms (e.g., pellets, granules or 
microparticles) are becoming more and more important on the pharmaceutical market, 
as they provide several advantages compared to single-unit dosage forms (e.g., tablets 
or capsules) (Ghebre-Sellassie 1994). Risks such as spontaneous drug release from a 
single-unit tablet due to damaged coating or its attachment in the stomach or intestine 
causing an irritation of the gastric or intestinal mucosa, are reduced by the use of 
multiunit forms (Adriaens et al. 2002). After disintegration of the tablets in the 
stomach, single units equal to or below 2 mm in diameter and having a density lower 
than 2.5 g/cm3 behave like a liquid and have a short transit time through the stomach 
avoiding drug accumulation (Clarke et al. 1993, 1995). Moreover, such small single 
units enable a more reproducible dispersion throughout the gastrointestinal tract 
leading to a reduction of drug release variations and an improved bioavailability. Thus, 
it results in a decrease in drug dose and side effects (Sandberg et al. 1988, Sivenius et 
al. 1988, Stefan et al. 1988, May and Rambeck 1989, Follonier and Doelker 1992, 
Abrahamsson et al. 1996, Amighi et al. 1998, Peh and Yuen 1997, Hosny et al. 1998). 
With regard to the final dosage form, the multiparticulates can be filled into hard 
gelatin capsules (Stegemann 1999, Chopra et al. 2002) or be compressed into 
disintegrating tablets (Flament et al. 1994, Maganti and Çelik 1994). The advantages 
of tableting multiparticulates include less difficulty in oesophageal transport, and thus 
a better patient compliance. Tablets can be prepared at a lower cost because of the 
higher production rate of tablets presses. The expensive control of capsule integrity 
after filling is also eliminated. In addition, tablets containing multiparticulates could be 
scored without losing the controlled release properties, which allows a more flexible 
dosing regimen (Bodmeier 1997).  
2  1 INTRODUCTION 
Sustained-release multiunit dosage forms can be achieved by compressing of coated or 
matrix-type multiparticulates such as pellets or micro tablets. Several studies have 
already reported that during the compression process, coated pellets may be damaged 
by interactions between the feeder, punches and die of the tablet press or between the 
components of the mixture leading to some increase in drug release (Lpez-Rodríguez 
et al. 1993, Beckert 1995, Wagner 1999). Matrix systems present the advantage that 
the release of the drug is not dependent on the properties and the state of the film 
coating. Moreover, micro tablets, which are tablets having a diameter of 2 mm or less, 
represent an interesting alternative to pellets. Since micro tablets are produced by 
compression, many steps of pellet production, like moisturizing, extruding, 
spheronizing, and drying can be avoided (Flemming and Mielck 1996). Furthermore, 
micro tablets are uniform in form and size and show a regular surface. 
Pellets or micro tablets are mixed with excipients before being compressed into 
multiunit tablets. The difference in form, size and density of the different mixing 
components are critical factors, which can influence the stability and demixing 
tendency of such mixtures. Some authors have recommended filler-binders that are 
almost equal in size to the pellets used (Aulton et al. 1994, Çelik and Maganti 1994, 
Flament et al. 1994, Lundqvist et al. 1997, Pinto et al. 1997), whereas others have 
demonstrated a reduction of segregation while using a fine microcrystalline cellulose 
like Avicel PH 101 (Haubitz et al. 1996, Wagner et al. 1999). Non-segregating 
mixtures of pellets or micro tablets and filler-binders are necessary to obtain tablets of 
uniform weight and drug content, and thus to ensure a high quality in production.  
 
The objective of this work was to investigate the influence of the size of single units 
(pellets or micro tablets) on the uniformity of the tablet weight and content of the 
active ingredient of the resulting tablets under pilot plant conditions. In order to 
achieve this goal, four different sizes of pellets in a range from 355 µm to 1700 µm 
and micro tablets of 2 mm in diameter were compressed into 13-mm tablets on a rotary 
tablet press (Korsch PH 230) within 1 hour. Weight and content variations were 
investigated and the percentage of rejected tablets was defined. The flow properties of 
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the different mixtures were determined according to DIN 53916 and using a self-
constructed conveyor belt. The influence of the filler composition on the flow 
properties was also studied. Finally, properties of the multiple unit dosage forms such 
as crushing strength, friability and disintegration time were reported as well as the 
effect of the compression process on the release of theophylline from multiunit tablets. 
CHAPTER 2 
LITERATURE REVIEW OF THE PRODUCTION OF MULTIUNIT TABLETS 
AND DESCRIPTION OF THE STUDY MODEL 
2.1 Literature review of the production of multiunit tablets 
2.1.1 Description of the single units used for the production of multiunit tablets 
Multiunit tablets are produced by compressing single units that are in general granules, 
pellets or micro tablets. According to Follonier and Doelker (1992), the granules are 
divided into microspheres and microcapsules. The methods for preparing granules are 
based either on physical methods such as fluidized bed granulation, spray-drying, 
spray-congealing and solvent evaporation, on physicochemical methods such as 
coacervation, or on chemical methods such as interfacial polymerisation (Por Li et al. 
1988). The production of pellets is a quite complex process, as it includes many steps 
such as moisturising, extruding, spheronising and drying (Kleinebudde 1998). 
Moreover, pellets present the major disadvantage of being irregular shaped particles 
(Munday 1994). Hence, micro tablets that are tablets having a diameter equal to or 
smaller than 2 mm could represent an interesting alternative to pellets since they are 
produced by compression (Flemming and Mielck 1995, 1996, Butler et al. 1998, Rey 
et al. 2000). Thus, many steps of pellets production can be avoided, defined sizes and 
strengths can be easily achieved and the variability within a batch can be minimised. 
Because of their uniform size, smooth surface, low porosity and high strength, micro 
tablets could be coated more reproducibly than usual pellets. They are more robust and 
they need less coating material (Munday 1994, Vecchio et al. 2000). Moreover, it is 
possible to produce micro tablets with higher drug contents than normal-sized tablets 
(Lennartz and Mielck 1998). 
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One way to achieve sustained-release multiunit tablets is to compress coated single 
units. The polymers used in the film-coating of solid dosage forms usually fall into 
two broad groups based on either cellulose or acrylic polymers (Bodmeier and 
Paeratakul 1994). Ethylcellulose is used frequently as coating material for the 
preparation of pellets. However, it forms quite brittle films that are not suitable for 
further tableting (Béchard and Leroux 1992, Tirkkonen and Paronen 1993, Maganti 
and Çelik 1994). Polyacrylates are more qualified for these purposes, as they are more 
flexible (Lehmann 1984, Lehmann et al. 1994, Lehmann and Süfke 1995, Beckert et 
al. 1996). 
In order to control the drug release of multiunit tablets, the film coating has to 
withstand the applied compaction pressure. The film can deform, but should not 
rupture. Damages to the coating would result in a loss of the sustained release 
properties and cause dose dumping. Several studies have reported on the formulation 
and the process parameters necessary to obtain pellet-containing tablets that have the 
same properties as the individual coated units (Beckert 1995, Bodmeier 1997, Wagner 
1999).  
Besides the well-known principle of film-tablets, most concepts of controlled release 
tablets are based on more or less compact porous or slowly eroding matrix structures. 
Sustained release matrix tablets are obtained by direct compression of drugs with spray 
dried polymer powders. Lehmann (1984) and Cameron et al. (1987) have described 
such systems using acrylic resins. A matrix is a uniform mixture of drug, excipients 
and polymer that is homogeneously fixed in a solid dosage form (Carstensen 2001). 
The drug substance, which has a solubility in the dissolution medium is dispersed in 
the matrix, which is insoluble in the dissolution medium. The matrix is more or less 
porous so that the liquid will intrude the matrix and will dissolve the drug substance.  
The production of matrix micro tablets has been already described (Rey et al. 1998, 
Sujja-areevath et al. 1998, Cox et al. 1999, De Brabander et al. 2000a+b) but until 
now, no studies have reported about the tableting of multiunit tablets consisting of 
matrix micro tablets.  
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2.1.2 Excipients for the tableting of multiunit tablets 
Compaction of multiparticulates into tablets could either result in disintegrating tablets 
providing a multiparticulate system during gastrointestinal transit or in intact tablets 
due to adhesion or partial fusion of the multiparticulates in a larger compact 
(Johansson et al. 1995). Ideally, the compacted single units should disintegrate rapidly 
into the individual units in gastrointestinal fluids; they should not stick together 
forming a non-disintegrating matrix during compaction (Chemtob et al. 1986, 
Sveinsson et al. 1993). Thus, various external excipients have to be added to single 
units to assist the compaction process (López-Rodríguez et al. 1993, Maganti and 
Çelik 1993). The ideal filler material used for the tableting of single units should 
prevent the direct contact of the units and act as cushioning agent during compression. 
Compaction forces have to be absorbed preferentially and mainly by the excipients in 
order to let the single units intact. The protective effect of different tableting excipients 
on the compression of granules is studied indirectly through dissolution studies 
(Torrado and Augsburger 1994). The amount of excipient used should be sufficient to 
separate and protect the units. Lehmann et al. (1990 and 1994) reported that an amount 
of filler and disintegrant between 30-50 % was necessary to reduce damages of coated 
pellets. When approximately 30 % of tableting excipients including disintegrants were 
compressed with the coated particles, the interspaces were filled and the pellets were 
separated. Hence, the tablets disintegrated rapidly and the damages of particles and 
changes of release profiles could be reduced to an insignificant level.  
Moreover, the addition of excipients should result in hard and rapidly disintegrating 
tablets at low compression forces. Flamment et al. 1994 have shown that tablets 
containing active pellets alone lacked the required hardness. Thus, inert granules were 
added to facilitate the cohesion of the tablet. According to the requirements of the 
European Pharmacopoeia, the multiunit tablets have to liberate the subunits within 15 
min. Besides their compaction properties, the excipients have to result in a uniform 
blend with the single units, avoiding segregation and therefore weight variation and 
poor drug content uniformity of the resulting tablets (Bodmeier 1997).  
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2.1.3 Microcrystalline cellulose as filler/binder for multiunit tablets  
Microcrystalline cellulose is certainly the most commonly used diluent for the 
compression of single units into tablets. Table 2.1 reviews studies dealing with the 
production of disintegrating sustained-released multiunit tablets containing 
microcrystalline cellulose as filler/binder. In certain studies, microcrystalline cellulose 
was used directly as supplied by the manufacturer whereas in other studies, it was first 
mixed with other additives and then granulated or extruded into pellets.  
Torrado and Augsburger (1994) have studied the protective effect of different 
excipients on the tableting of theophylline granules coated with Eudragit RS. Two 
excipients namely polyethylene glycol 3350 and microcrystalline cellulose were found 
to cause the lowest damages of the granules during tableting. These results were 
explained with the yield pressure of the two excipients, which were lower than that of 
the pellets. Therefore, the energy of compaction was absorbed by the external 
excipients and these excipients were preferentially deformed. This protective effect of 
microcrystalline cellulose was confirmed in another study by Tunón and Alderborn 
(2001) in which the pellets after disintegration of the tablets were similar in size to the 
original pellets. A very few pellet fragments were obtained during disintegration. The 
compaction had only affected the shape of the individual pellets resulting in more 
irregular pellets. Moreover, Wagner et al. (2000a) observed that pellets compressed 
with the fine microcrystalline cellulose Avicel PH 101 (x50 = 50 µm) remained 
approximately spherical. The fine Avicel PH 101 was able to fill the pores of the 
pellets lattice much more tightly than coarse Avicel granules (x50 = 194 µm).  
 
In regards to the physical properties of multiunit dosage forms, López-Rodríguez et al. 
(1993) and Maganti and Çelik (1993) showed that tablets of coated pellets containing 
microcrystalline cellulose presented a higher crushing strength than tablets of coated 
pellets without microcrystalline cellulose. External excipients, being small and 
irregular particles, when added to the pellets, introduce new bounding sites, which lead 
to an increase in the number of potential cohesive and adhesive bonds, thereby 
producing relatively strong compacts. Mixtures consisting of pellets and 
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microcrystalline cellulose as external additive were found to be more compressible and 
produced stronger compacts than the tableting of pellets with pregelatinized starch or 
soy polysaccharide. Moreover, the size of microcrystalline cellulose had shown an 
effect on the crushing strength of tablets. Tablets compressed with Avicel PH 101 had 
demonstrated a significantly higher crushing strength than tablets produced with 
Avicel granules (Wagner et al. 1999).  
Concerning the disintegration time, the use of microcrystalline cellulose as external 
excipients has provided compacts that have disintegrated and regenerated the coated 
particles within less than 10 s as opposed to 7-10 min for other excipients such as 
spray dried lactose, spray dried sorbitol, compressible sucrose, polyethylene glycol 
8000, pregelatinized starch (Béchard and Leroux 1992).  
In addition to the physical properties, multiunit tablets containing microcrystalline 
cellulose showed low friability with values below 1 %. It was also observed that the 
friability depends on the microcapsules content. 50 % of microcapsules and Avicel 
showed a friability of 0.89 %, whereas at 75 % of microcapsules, the tablet could not 
be held together. In general, Avicel allowed the incorporation of a greater percentage 
(w/w) of single units without serious degradation of tablet performance than other 
excipients (Prapaitrakul and Whitworth 1990, Flament et al. 1994). An increase in the 
amount of single units had logically an effect on the other physical properties of the 
multi unit tablets. Increasing the single unit content decreases the tablet breaking load 
and the disintegration time. Pellets that are large and spherical in shape as compared to 
small, irregular powder particles, have a low surface to volume ratio, and this might 
result in a decreased area of contact between the particles as they consolidate 
(Lundqvist et al. 1997). According to the studies from López-Rodríguez et al. (1993), 
Prapaitrakul and Whitworth (1990) and Aulton et al. (1994), the optimal amount of 
microcrystalline cellulose used to compress single units without serious degradation of 
tablet performance varied between 25 % and 40 % (w/w), corresponding to an amount 
of single units from 60 % to 75 % (w/w). Moreover, Beckert et al. (1998) have 
observed that a pellet content in the range of 50-70 % (w/w) resulted in multiunit 
tablets that complied with the requirements for weight and content uniformity of 
European Pharmacopoeia. The explication was based on the percolation theory. 
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Stauffer (1985) used the term percolation to describe continuous structures (clusters) 
formed throughout the length, width and height of a system. When a binary system is 
considered, it depends on the concentration of each component, whether only one or 
both components percolate. The minimum concentration of a component at which a 
percolating cluster may be found is called the percolation threshold. Below this 
concentration only isolated clusters of one component can exist. Infinite clusters form 
above the percolation threshold. A bicoherent structure builds up if both components 
percolate. Beckert (1995) found that up to 50 % (w/w) of pellets, a percolating cluster 
of pellets that prevent segregation was ensured. 
 
On one hand, a lot of authors agree that the particle size of external additives is a 
parameter of major importance in order to obtain a uniform mixture. Segregation is 
influenced by factors such as markedly differing particle size, density or shape. The 
difference in size distribution between powders and pellets is expected to lead to 
segregation, resulting in tableting problems, such as weight variation and poor content 
uniformity. Therefore, the excipients should have a mean diameter close to that of the 
active single units to produce a stable mixture. Consequently, it seems necessary to 
choose a large particle size of excipients or to prepare placebo pellets or granules 
(Aulton et al. 1994, Çelik and Maganti 1994, Flament et al. 1994, Beckert et al. 1996, 
Pinto et al. 1997, Lundqvist et al. 1997). On the other hand, Haubitz et al. (1996) 
compressed mixtures consisting of 70 % (w/w) theophylline pellets (800-1250 µm) 
and the fine microcrystalline cellulose Avicel PH 101 (x50 = 50 µm) and observed that 
in spite of the greater differences of particle sizes no distinct segregation occurred. In 
addition, Wagner et al. (1999, 2000b) investigated the pellet-distribution in single 
tablets via image analysis. The most homogeneous distribution of the pellets, 
particularly at intermediate and high machine speed was achieved with the fine Avicel 
PH 101. On the contrary to Avicel PH 101, coarser filler-binders led to segregation 
within the tablets at high machine speed. Avicel PH 101 has a large surface area and a 
fibrous surface texture, thus building a close percolating infinite cluster stabilising the 
pellets at their location in the mixture. A homogeneous distribution of the single units 
within the tablet presents also the advantage of divisible tablets. 
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Type of 
microcrystalline 
cellulose 
not defined 
Avicel PH 101 or 
Avicel PH 200 
Avicel PH 102 
Emocel 50M 
Avicel PH 101 
Avicel PH 200 
Content of single 
units [% (w/w)] 
15-75 
60 
75-95 
80-90 
33 
60 
Coating 
cellulose acetate 
butyrate 
ethylcellulose 
Eudragit RS 
- 
ethylcellulose 
Eudragit RS /RL 
Drug 
phenylpropanol-
amine resin 
complexes 
chlor-
pheniramine 
maleate 
acetylsalicylic 
acid 
propranolol HCl 
indomethacin 
ibuprofen 
Size of single 
unit [µm] 
125-250 
250-420 
420-590 
590-840 
600-850 
500-1000 
147-297 
10000 
Single unit 
microcapsules 
pellets 
pellets 
pellets 
microcapsules 
pellets 
Table 2.1  Review of studies on the tableting of disintegrating multiunit tablets using microcrystalline cellulose as filler/binder 
Authors 
Prapaitrakul et 
al. (1989, 1990) 
Béchard and 
Leroux (1992) 
López-Rodríguez 
et al. (1993) 
Maganti and 
Çelik (1993) 
Tirkkonen and 
Paronen (1993) 
Aulton et al. 
(1994) 
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Type of 
microcrystalline 
cellulose  
granules of 
microcrystalline 
cellulose (250-
1000 µm) 
granules of 
Avicel PH 101 
(710-850 µm) 
Avicel PH 102 
Avicel PH 200 
Avicel PH 101 
Avicel PH 101 or 
pellets of Avicel 
PH 101 (840-
1190 µm) 
Content of single 
units [% (w/w)] 
50 
25 
50 
10-90 
70 
10-50 
Coating 
Eudragit NE 
Eudragit RS 
Eudragit RS/RL 
Eudragit L 30D-
55 
Eudragit NE 
Eudragit L 30D-
55 
Drug 
theophylline 
theophylline 
theophylline 
bisacodyl 
theophylline 
theophylline 
Size of single 
unit [µm] 
355-1000 
410-590 
700-1600 
1000-2000 
500-1250 
800-1250 
840-1190 
Single unit 
pellets 
pellets 
pellets 
pellets 
pellets 
pellets 
Authors 
Flament et al. 
(1994) 
Torrado and 
Augsburger 
(1994) 
Heinämäki et al. 
(1995) 
Beckert et al. 
(1996) 
Haubitz et al. 
(1996) 
Mount et al. 
(1996) 
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Type of 
microcrystalline 
cellulose  
Avicel PH 101 
pellets of Avicel 
PH 101 (1000-
1400 µm) 
pellets of Avicel 
PH 101 (1000-
1400 µm) 
Avicel PH 101 or 
Avicel PH 200 or 
Avicel granules 
(500-1000 µm) 
Avicel PH 200 
pellets of Avicel 
PH 101 (1000-
1400 µm) 
Content of single 
units [% (w/w)] 
50 
20-60 
15-50 
10-70 
30-60 
20-60 
Coating 
Eudragit S-100 
Eudragit RS 
- 
- 
Eudragit L 30D-
55 
- 
ethylcellulose 
methylcellulose 
Drug 
pseudo-
ephedrine HCl 
pseudo-
ephedrine base 
riboflavin 
indomethacin 
bisacodyl 
placebo (sugar) 
theophylline 
Size of single 
unit [µm] 
840-1000 
1000-1400 
1000-1400 
800-1250 
1000-1190 
1000-1400 
Single unit 
pellets 
pellets 
pellets 
pellets 
pellets 
pellets 
Authors 
Li et al. (1997) 
Lundqvist et al. 
(1997) 
Pinto et al. 
(1997) 
Beckert et al. 
(1998) 
Kühl and Mielck. 
(1998) 
Lundqvist et al. 
(1998) 
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Type of 
microcrystalline 
cellulose  
Avicel PH 101 or 
Avicel granules 
(194, 621 and 
1055 µm) 
Avicel PH 101 or 
Avicel granules 
(194 µm) 
pellets of Avicel 
PH 101 (710-
1000 µm) 
pellets of Avicel 
PH 101 (180-300 
or 710-900 µm) 
 
 
Content of single 
units [% (w/w)] 
70 
60-70 
12.5 
12.5 
 
 
Coating 
Eudragit FS 30D 
Eudragit FS 30D 
- 
ethylcellulose 
 
 
Drug 
coloured 
placebos 
bisacodyl 
coloured 
placebos 
salicylic acid 
 
 
Size of single 
unit [µm] 
850-1000 
1000 
1000-1250 
1000-1250 
 
 
Single unit 
pellets 
pellets 
pellets 
pellets 
 
 
Authors 
Wagner et al. 
(1999) 
Wagner et al. 
(2000 a+b) 
Tunón and 
Alderborn (2001) 
Tunón and 
Alderborn (2002) 
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2.2 Description of the study model 
30 kg-batches consisting of 60 % (w/w) single units and excipients were compressed 
on a rotary tablet press (Korsch PH 230/17) for 1 hour in order to investigate the 
influence of the size of the single units and the composition of fillers on the weight 
variation and content uniformity of the multiunit tablets. 
2.2.1 Types of pellets and micro tablets as single units 
Four categories of pellet sizes and two types of micro tablets with a diameter of 2 mm 
were used as single units to be compressed into multiunit tablets (Table 2.2 and Table 
2.3). Placebo micro tablets consisting of 99 % (w/w) StarLac and 1 % magnesium 
stearate were compressed on an instrumented Korsch Pharma 230/17 (see Chapter 6) 
and they were used for the study of uniformity of weight. Theophylline micro tablets 
were used to study the uniformity of micro tablets per tablet and the dissolution 
behaviour of a sustained release formulation. The sustained-release micro tablets were 
based on a polymer matrix, which delivers the drug within 8 hours (see Chapter 5). 
Rey et al. (2000) have already described such micro tablets. The production of 
theophylline micro tablets was divided into two steps: production of theophylline 
granules and tableting of the granules with 2 % magnesium stearate. Theophylline 
granules were prepared in a fluidised bed granulator (WSG 5, Glatt GmbH) by top 
spraying a 6 % aqueous dispersion of Eudragit RS 30 D plus 10 % triethyl citrate onto 
a powder mixture of 70 % theophylline, 12 % Eudragit RS PO and 12 % magnesium 
stearate. The theophylline micro tablets were compressed on an instrumented rotary 
tablet press Kilian TX 40 at a compaction pressure of 200 MPa (see Chapter 6). 
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Table 2.2 Description of the different pellets used for the tableting of multiunit 
tablets 
Single unit x10 x50 x90 Composition 
Suglets 355-425 (batch No. 104 F) 288 390 532 Sugar 
spheres 
Suglets 850-1000 (batch No. 106 E) 660 950 1374 Sugar 
spheres 
Suglets 1180-1400 (batch No. 909 T) 799 1118 1521 Sugar 
spheres 
Pellets, neutral 1400-1700* 1411 1466 1596 Saccharose, 
corn starch 
* data from the supplier 
 
 
Table 2.3 Properties of the different micro tablets used for the tableting of 
multiunit tablets 
Type of 
micro tablets 
Diameter 
[mm] 
Composition 
[w/w] 
Tablet weight 
[mg] 
± S.D. 
Crushing 
strength 
[N] ± S.D. 
Placebo 2 
StarLac 99 % 
magnesium stearate 1 % 
7.02 ± 0.11 7.6 ± 1.5 
Theophylline 2 
theophylline granules 98 % 
magnesium stearate 2 % 
7.24 ± 0.08 10.8 ± 0.4 
 
2.2.2 Filler/binders for multiunit tablets 
The filler used for the tableting of multiunit tablets was either a fine microcrystalline 
cellulose Avicel PH 101 (x50 = 50 µm) or a binary mixture of 30 % (w/w) Avicel PH 
101 and 70 % (w/w) of a coarser microcrystalline cellulose Avicel PH 200 (x50 = 180 
µm). The other excipients were 4 % (w/w) Kollidon CL as disintegrant, 0.1 to 0.4 % 
(w/w) Aerosil 200 as glidant and 0.5 % (w/w) magnesium stearate as lubricant. The 
amount of filler was varied in a range of 35.1-35.4 % depending of the amount of 
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Aerosil 200. The composition of the different mixtures is described in Chapter 6, 
Table 6.7. 
2.2.3 Tablet press parameters for the production of multiunit tablets 
Mixtures were compressed on an instrumented rotary tablet press Korsch PH 230/17, 
equipped with 8 pairs of round flat-faced B-tooling punches and a diameter of 13 mm 
at a compaction force of 150 MPa. An intermediate machine speed of 50 rpm was used 
to compress the multiunit tablets with an average output of 24000 tablets per hour. The 
tablet weight was adjusted at the beginning between 0.95-1.00 g corresponding to a 
theophylline content of 390-410 mg per tablet. During the process, the parameters of 
the machine were not changed in order to correct the tablet mass. The time needed to 
compress 30 kg of a pilot plant batch was roughly 1 hour. 
Due to the fact that large pellets or micro tablets are compressed into multiunit tablets 
using fine filler/binders, there is a demixing tendency in the feeding system of the 
rotary tablet press. In general a gravity or a force feeder could be used. A preliminary 
study has shown that the use of a force feeder was not suitable for tableting of micro 
tablets. The force feeder is composed of two wheels consisting of stirring blades, 
which can damage the micro tablets through friction. Moreover, it was observed that 
the tablet weight decreased significantly during the tableting process (Figure 2.1). This 
was the result of segregation of the micro tablets within the force feeder by the 
centrifugal forces of the stirring blades. Therefore for all tableting experiments a 
gravity feeder was used. 
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Figure 2.1 Variation of tablet weight during the tableting of 60 % (w/w) placebo 
micro tablets, 35.2 % Avicel PH 101, 4 % Kollidon CL, 0.3 % Aerosil 
200 and 0.5 % magnesium stearate on a Korsch Pharma 230/17 rotary 
tablet press at 50 rpm and using a force feeder. Each point represents 
n=20 tablets. Error bars represent the 95 % confidence interval 
 
CHAPTER 3 
INFLUENCE OF SINGLE UNIT SIZE ON THE TABLET WEIGHT AND 
UNIFORMITY OF SINGLE UNITS PER TABLET 
3.1 Introduction 
Multiunit tablets consisting of single units of varying sizes and excipients were 
compressed on an instrumented rotary tablet press Korsch Pharma 230/17. The aim of 
the study was to adjust the system tablet formulation/tablet press in order to produce 
multiunit tablets that guarantee weight uniformity and uniformity of single units within 
one tablet under pilot plant conditions. As a reference experiment Ludipress, known as 
a free-flowing material for direct compression was firstly compressed with 0.5 % 
magnesium stearate. The tableting of Ludipress was then compared to the tableting of 
the different batches of single units.  
 
3.2 Tableting of Ludipress 
3.2.1 Characterisation of Ludipress 
Ludipress is an alpha-lactose monohydrate based granule that was introduced into the 
pharmaceutical market in 1988. Besides -lactose monohydrate, it contains Kollidon 
30 and Kollidon CL. Concentrations and attributes of these three constituents are 
described in Table 3.1. Lang (1986) and Bolhuis and Chowan (1996) have reported 
applications of Ludipress as an excipient for the manufacture of tablets by direct 
compression. 
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Table 3.1  Attributes and concentration of the constituents of Ludipress 
Constituent Concentration [%] Attribute 
-Lactose monohydrate 93.0 ± 2.0 Filler, binder 
Kollidon 30 (polyvinylpyrrolidone) 3.5 ± 0.5 Binder 
Kollidon CL (crospovidone) 3.5 ± 0.5 Disintegrant 
 
 
Ludipress is a coprocessed product obtained by a special granulation process of -
lactose monohydrate particles with polyvinylpyrrolidone and crospovidone. It has been 
demonstrated that the use of specially designed coprocessed materials could improve 
the advantages of the starting materials while overcoming their respective 
disadvantages (York 1992). Most important are the binding and blending properties of 
these excipients, which must be better than those of a physical mixture of the starting 
materials.  
The granule characteristics of Ludipress have been investigated in several studies 
(Baykara et al. 1991, Muñoz-Ruiz et al. 1992, Rubensdörfer 1993, Heinz et al. 2000). 
Flowability of powders is an important characteristic during tableting as it can 
critically affect the uniformity of tablet weight and thus the coefficient of weight 
variation. Flow properties are generally determined using angle of repose, flow rate 
and/or bulk density measurements. Surface properties and particle shape are also 
parameters that influence the powder flow directly.  
The morphology of Ludipress has been investigated by scanning electron microscopy 
(Schmidt and Rubensdörfer 1994). It was shown that Ludipress is made up of a large 
number of small crystals leading to granules with smooth surfaces and spherical 
shapes. Rheological characteristics of Ludipress have been compared to the physical 
blend of the base materials of Ludipress and other filler/binders such as Avicel PH 
101, Avicel PH 200, Cellactose, Tablettose, Fast-Flo Lactose, anhydrous -lactose and 
it was found that Ludipress had smaller angle of repose, better flow rate and smaller 
Hausner ratio (Muñoz-Ruiz et al. 1993, Schmidt and Rubensdörfer 1994, Goto et al. 
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1999). Table 3.2 shows the powder characteristics of Ludipress that was used in this 
work. With an angle of repose of 30.0° and a Hausner-ratio of 1.13 (values below 1.25 
indicate good flow property, Hausner 1967), it was confirmed that Ludipress is a 
suitable excipient for direct compression.  
 
Table 3.2 Characteristics of Ludipress (Lot No. 62_1227) 
Component Angle of 
repose [°] 
Flow rate 
[ml/s] 
Bulk 
density 
[g/ml] 
Tapped 
density 
[g/ml] 
Hausner-
ratio 
Particle size 
distribution [µm] 
Ludipress 
Lot No. 
62_1227 
30.0 17.26 0.581 0.658 1.13 
   x10 = 52.44 
   x50 = 179.30 
   x90 = 385.15 
 
3.2.2 Tableting 
Powder characteristics of Ludipress confirmed that it is a suitable excipient for direct 
compression. However, the compression of pure Ludipress encounters high frictions in 
the dies, so that the addition of a lubricant, such as magnesium stearate, is necessary. 
Magnesium stearate has been mixed with Ludipress in concentrations varying from 0.5 
to 2 % to reduce frictional forces (Plaizier-Vercammen and Van den Bossche 1992, 
Schuchmann 1999). 
 
A 30 kg-batch of Ludipress and 0.5 % of magnesium stearate was compressed at 150 
MPa on a rotary press (Korsch Pharma 230/17). The filling depth and the band height 
were adjusted at the beginning of the tableting process and the adjustments were kept 
constant during the next 60 min. Samples of 20 tablets were taken randomly every 3 
minutes within 60 min and the weight variations were analysed. Figure 3.1 depicts the 
weight variation of tablets during compression and the limits of tolerance according to 
the European Pharmacopoeia 4th edition.  
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Figure 3.1 Weight variation of tablets consisting of 99.5 % (w/w) Ludipress and 
0.5 % magnesium stearate during the compression. () Average weight, 
(– –) ± 5 % limit of tolerance, () ± 10 % limit of tolerance.  
 
As shown in Figure 3.1, it was observed that the weight of two tablets in the first 
sample (time 0 min) exceeded the 5 % limit but not the 10 % limit of tolerance.  
Although Ludipress is known as a free-flowing powder, it took up to 9 minutes until 
the machine delivered tablets with a constant weight. The coefficient of weight 
variation for the total number of 400 tablets was 1.9 %. Omitting the first 60 sampled 
tablets, corresponding to 9 minutes of production, the coefficient of variation 
decreased to 1.3 %. Several authors have reported a coefficient of variation of less than 
1 % for the weight uniformity of tablets consisting of Ludipress and magnesium 
stearate but the tests were performed on only 20 tablets (Plaizier-Vercammen and Van 
den Bossche 1992, Muñoz-Ruiz et al. 1993). The results indicate, that after an initial 
phase where the powder settled within the feeder, a constant tablet weight was 
observed. Due to its good flow properties, Ludipress could act as a reference material 
for trials with pellets and micro tablets. 
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3.3 Tableting of pellets and micro tablets under pilot plant conditions 
The influence of the single unit size (pellets in a range of 355 to 1700 µm or micro 
tablets of 2 mm) on the various properties of the multiunit tablets prepared thereof was 
studied. The aim was to investigate to which extent multiunit tablets containing single 
units of varying diameter comply with the requirements of the European 
Pharmacopoeia 4th edition.  
 
Firstly, the optimum single unit content of tablets containing pellets or micro tablets 
was determined. 3 kg-batches containing 60 %, 70 % and 80 % (w/w) of micro tablets 
were compressed at 150 MPa on a rotary tablet press (Korsch Pharma 230/17). The 
tablet press was fitted with eight 13 mm-flat-faced punches and the speed of the 
machine was set at 50 rpm. Table 3.3 shows the composition and physical properties 
of the resulting tablets such as crushing strength and friability.  
 
Table 3.3 Composition and properties of the multiunit tablets  
Micro tablets (Ø = 2 mm) [%] 60 70 80 
Avicel PH 101 [%] 35.2 25.2 15.2 
Kollidon CL [%] 4 4 4 
Aerosil [%] 0.3 0.3 0.3 
Magnesium stearate [%] 0.5 0.5 0.5 
Crushing strength [N] 77 41 29 
Friability [%] 0.37 >> 10 % >> 10 % 
 
It was demonstrated that the crushing strength of the tablets decreased significantly 
from 77 to 29 N by increasing the content of micro tablets from 60 % to 80 %. Tablets 
with a hardness of 29 N were extremely weak. Moreover, the friability test of tablets 
containing more than 60 % micro tablets failed, as most of the tablets were broken 
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after 100 revolutions of the drum. Thus, a maximum single unit content of 60 % (w/w) 
was established for the pilot plant experiments.  
 
Five different batches of 30 kg, consisting of pellets or micro tablets and excipients, 
were compressed to investigate the influence of the single unit size on the tablet 
weight and content uniformity under pilot plant conditions.  
60 % (w/w) pellets in a range of 355 µm to 1700 µm or micro tablets of 2 mm were 
mixed with Avicel PH 101 as a filler, Kollidon CL as a binder, Aerosil 200 as a glidant 
and magnesium stearate as a lubricant. The amount of Kollidon CL and magnesium 
stearate was fixed at a level of 4 % and 0.5 %, respectively. The amount of the 
microcrystalline cellulose, Avicel PH 101, was varied in a range of 35.1 % to 35.4 % 
according to the amount of Aerosil 200 needed to allow the mixture to flow properly 
out of the funnel. The composition of the five mixtures is described in Chapter 6 
(mixtures 2, 3, 4, 5 and 6, Table 6.7). Tablets were compressed using an instrumented 
rotary tablet press (Korsch Pharma 230/17) equipped with a gravity feeder. 8 of the 17 
punch stations were equipped with 13 mm flat-faced B-tooling. The machine speed 
and the compression force were set at 50 rpm and 150 MPa, respectively. The weight 
of the tablets was adjusted between 0.9 g and 1 g at the beginning of the compression 
process. During the 60 min of tableting, the tablet press parameters were kept constant. 
 
3.3.1 Weight uniformity 
The European Pharmacopoeia 4th edition gives specifications to assure the quality of 
tablets by testing the weight uniformity. The uniformity of weight is performed on 20 
tablets taken randomly. For tablets greater than 250 mg, not more than 2 of the 
individual weights deviate from the average weight by more than 5 % and no tablet 
deviates by more than 10 %.  
During the production of 30 kg-batches, approximately 24 000 tablets were produced 
within 60 min. In order to characterise the tablet weight variations and the tablet 
weight distribution during the tableting process, samples of 20 tablets were withdrawn 
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every 3 min during the 60 min production time and analysed. The average weight of 
all tablets and the 5 % and 10 % limits of tolerance were calculated.  
 
Tablets consisting of pellets in a range of 355-425 µm (mixture 2, Table 6.7) have 
shown excellent weight uniformity during the production time. The production time 
began after the initial phase; as the tablet press has delivered tablets with constant 
weight (see Tableting of Ludipress, section 3.2). Figure 3.2 depicts the weights of 20 
tablets sampled every 3 min during 60 min, the average weight and the 5 % and 10 % 
limits of tolerance. As shown in the figure, the weights of individual tablets were 
tightly distributed over the average weight. None of the tablets has exceeded the 5 % 
tolerance limits. The relative standard deviation of the weight of all investigated 
tablets was found to be low at 1.08 %. 
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Figure 3.2 Weight variation of tablets during the compression of pellets Ø=355-
425 µm and Avicel PH 101 as a filler. () Average weight, (– –) ± 5 % 
limit of tolerance, () ± 10 % limit of tolerance. 
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Figures 3.3, 3.4, 3.5 and 3.6 depict the weight variation of tablets during the 
compression of pellets in a range of 850 to 1700 µm (mixtures 3, 4 and 5, Table 6.7) 
and micro tablets with 2 mm in diameter (mixture 6, Table 6.7). The results of the 
weight variation analysis of Ludipress and the multiunit tablets are summarised in 
Table 3.4. Though the amount of Aerosil was optimised for each batch, increasing the 
single unit size in a range of 355 µm to 1700 µm led to a significant increase of the 
weight variation of the multiunit tablets from 1.08 % to 2.90 %. Above a pellet size of 
850 µm, the weights of the multiunit tablets showed a higher deviation from the 
average weight than pellets in a range of 355-425 µm. Tablets consisting of pellets in a 
range of 1400-1700 µm have demonstrated the highest weight variation (2.90 %) 
(Figure 3.5). However, tablets consisting of micro tablets have shown a coefficient of 
variation of 2.56 %, which was not more than the coefficient of variation of pellets in a 
range of 1180-1400 µm. Moreover, tablets containing single units in a range of 850 
µm to 2 mm were above the 5 % limit of tolerance. However, none of the tablets 
exceeded the 10 % limit of tolerance during the tableting of all batches.  
During tableting of multiunit tablets, the filling hopper was refilled several times in 
order to maintain a constant powder level. The arrows on Figures 3.3, 3.4, 3.5 and 3.6 
indicate the refilling of the hopper. It was observed that the refilling of the hopper was 
not correlated with the tablet weight variations.  
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Figure 3.3 Weight variation of tablets during the compression of pellets Ø=850-
1000 µm and Avicel PH 101 as a filler. () Average weight, (– –) ± 5 % 
limit of tolerance, () ± 10 % limit of tolerance,  refilling of the 
hopper 
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Figure 3.4 Weight variation of tablets during the compression of pellets Ø=1180-
1400 µm and Avicel PH 101 as a filler. () Average weight, (– –) ± 5 % 
limit of tolerance, () ± 10 % limit of tolerance,  refilling of the 
hopper 
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Figure 3.5 Weight variation of tablets during the compression of pellets Ø=1400-
1700 µm and Avicel PH 101 as a filler. () Average weight, (– –) ± 5 % 
limit of tolerance, () ± 10 % limit of tolerance,  refilling of the 
hopper 
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Figure 3.6 Weight variation of tablets during the compression of micro tablets of 2 
mm in diameter and Avicel PH 101 as a filler. () Average weight, (– –) 
± 5 % limit of tolerance, () ± 10 % limit of tolerance, refilling of 
the hopper 
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Table 3.4 Analysis of weight variations of Ludipress and multiunit tablets* 
 
Ludipress Pellets 
355-425 
µm 
Pellets 
850-1000 
µm 
Pellets 
1180-
1400 µm 
Pellets 
1400-
1700 µm 
Micro 
tablets 
2000 µm 
Tablet weight 
average [g] ± 
S.D. 
0.9286 
± 0.0127 
0.9761 
± 0.0105 
1.0729 
± 0.0254 
0.9136 
± 0.0251 
0.9514 
± 0.0276 
1.0783 
± 0.0276 
Coefficient of 
variation [%] 1.37 1.08 2.37 2.75 2.90 2.56 
Total number of 
tablets produced 19200 22800 19200 24000 24000 22400 
Total number of 
sampled tablets 340 400 340 420 420 380 
Number of 
tablets above the 
5 % limits of 
tolerance 
0 0 10 27 37 21 
Number of 
tablets above the 
10 % limits of 
tolerance 
0 0 0 0 0 0 
Real percentage 
of rejected 
tablets** [%] 
0-0.8 0-0.7 1.3-5.6 3.9-10.6 5.8-11.8 2.9-7.9 
*The initial phase was not taken into account 
**according to Schaafsma and Willemze (1973) 
 
The Pharmacopoeias give the specifications required for a sample of 20 tablets to 
present the quality characteristic “uniformity of weight”. According to the European 
Pharmacopoeia, there are two possibilities, either the sample of 20 tablets meets the 
specifications or it does not. However, pharmacopoeias do not have specifications on 
how production can perform a quality with a high degree of acceptance probability. 
The acceptance probability describes the probability with which a sample taken 
randomly during the production process will satisfy the quality requirements. From the 
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production point of view, a high acceptance probability of 99 % or more is logically 
expected. 
Altenschmidt and Häusler (1998) have presented a statistical interpretation of the 
European Pharmacopoeia specifications. They have derived process limits to guarantee 
a production with a high degree of acceptance probability. Figure 3.7 depicts the 
acceptance probability as a function of the coefficient of variation in the case of ideal 
production; meaning that the average of the production corresponds to the desired 
average. It was observed that the degree of the acceptance probability is correlated 
with the coefficient of variation. An increasing coefficient of variation leads to a 
decreasing acceptance probability. In order to produce tablets, which satisfy the 
quality requirements with 99 % of acceptance probability, the coefficient of variation 
is limited. The limit of the coefficient of variation depends on the weight of the tablet; 
tablets weighing 250 mg or more have a limit of 2.2 %, tablets in a range of 80-250 mg 
have a limit of 3.3 %, and tablets of 80 mg or less have a limit of 4.4 %. Furthermore, 
in case the actual average drifts from the desired average, the limit of the coefficient of 
variation decreases. Figure 3.8 illustrates the allowed deviation of the average as a 
function of the coefficient of variation with 99 % of acceptance probability. As long as 
the process parameters are below the curve, the production process will perform a 
quality with a degree of 99 % of acceptance probability.  
As regards the analysis of weight variations of multiunit tablets (Table 3.4), the 
coefficients of variation, determined after the initial phase where the powder settled 
within the feeder, varied between 1.08 and 2.90 %. Considering that the tablet weight 
was more than 250 mg and that the production was performed in the ideal case where 
the actual weight average corresponds to the desired average, only the tableting of 
pellets in a range of 355-425 µm have demonstrated 99 % of acceptance probability 
(Figure 3.7). Moreover, it means also that a deviation of the weight average up to 2.9 
% is allowed in order to assure an acceptance probability of 99 % (Figure 3.8). The 
acceptance probabilities of the batches consisting of pellets in a range of 850-1700 µm 
and micro tablets were decreased in a range of 75-95 %.  
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Figure 3.7 Acceptance probability in ideal production case for tablets weighing (-) 
250 mg and more, (-) from 80 to 250 mg, (--) 80 mg and less 
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Figure 3.8 Allowed deviation of the average as a function of the coefficient of 
variation with 99 % acceptance probability for tablets weighing (-) 250 
mg and more, (-) from 80 to 250 mg, (--) 80 mg and less 
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From the point of view of the manufacturer, it is important to determine the real 
percentage of rejected tablets during the production. According to Schaafsma and 
Willemze (1973), it is possible to estimate statistically the real percentage of rejected 
tablets with 99 % of probability from the percentage of rejected tablets obtained during 
a process by using tables of confidence interval. The percentage of rejected tablets was 
defined as the percentage of tablets, which weights were above the 5 % and/or the 10 
% limits of tolerance of the European Pharmacopoeia. Thus, the real percentage of 
rejected tablets was determined by reporting the total number of sampled tablets and 
the number of tablets, which weight exceeded the 5 % and/or the 10 % limits of 
tolerance (Table 3.4) into the table of 99 % confidence limits (Schaafsma and 
Willemze 1973, Table H, p 466-467). The real percentages of rejected tablets from the 
tableting of Ludipress and multiunit tablets are depicted in Table 3.4. The real 
percentage of rejected tablets is greater than the first value, or smaller than the second 
value with 99 % of probability. It means also that the real percentage of rejected 
tablets is within the written interval with 98 % probability. As shown in Table 3.4, 
increasing the pellet size led to a higher real percentage of rejected tablets. It is 
interesting to note that tablets consisting of pellets in a range of 355-425 µm provided 
similar percentage of rejected tablets as the free-flowing excipient Ludipress with less 
than 0.7 % rejects with a 99 % probability.  
 
3.3.2 Uniformity of micro tablets per multiunit tablet 
The uniformity of micro tablets per tablet was investigated for multiunit tablets 
consisting of theophylline micro tablets. The theophylline content of micro tablet was 
constant and was determined to be 68.5 % (± 0.4) by UV-spectrophotometry at 271.2 
nm (see Chapter 6).  
A method consisting of counting the micro tablets was developed to determine the 
content of micro tablets per multiunit tablet. Firstly, it was checked if the counting 
method was reliable by evaluating a correlation between the counting method and the 
UV-method. 
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For the counting method, a multiunit tablet was placed on a sieve No. 5 (mesh size 
0.315 mm) and the tablet was disintegrated by pouring water. The isolated micro 
tablets were counted. Micro tablets present the advantage that they remain nearly 
intact after compression into multiunit tablets. Nevertheless, the broken micro tablets 
were reconstituted optically. The theophylline content of tablets was determined using 
UV-spectrophotometry and compared to the number of micro tablets per tablet. The 
linear regression and the coefficient of determination were calculated. A good 
correlation (R2 = 0.9807) was found between theophylline content and the number of 
micro tablets per tablets (Figure 3.9). As a result, it was demonstrated that the counting 
method was adequate in order to determine the content of micro tablets per tablet. 
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Figure 3.9 Correlation between theophylline content determined by UV- 
spectrophotometry and the number of micro tablets per tablet.  
 
A 30 kg-batch containing 60 % (w/w) micro tablets (mixture 6, Table 6.7) was 
compressed for 60 min on a rotary press (Korsch Pharma 230/17). The total number of 
tablets produced was 24000, 55 multiunit tablets were taken at random within 60 min 
and weighed on an analytical balance. The tablets were then disintegrated in water and 
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the liberated micro tablets were counted. The content of micro tablets in % based on 
the weight of the multiunit tablet was calculated. The results of the 55 tablets are 
represented in Table 3.5.  
 
Table 3.5 Content of micro tablets per multiunit tablet 
Total number of tablets produced  22400 
Total number of analysed tablets   55 
Average weight of theophylline micro tablets [mg]  7.24 
Content of micro tablets per multiunit tablets  [% (w/w)] 
± S.D. 
 61.29  
± 2.05 
Coefficient of variation [%]  3.35 
 
The average content of micro tablets from 55 multiunit tablets was found at a level of 
61.29 % (w/w), which is slightly higher than the initial content of the tableting mixture 
(60 %). This difference can be attributed to the tableting process. Air movements 
produced by the rotor of the machine set at 50 rpm and by the lower punch going 
down just before the filling of the die can lead to a loss of fine powder and 
consequently to an increase of the content of micro tablets per tablet (Egermann 1991). 
 
3.3.3 Correlation between number of micro tablets per tablet and tablet weight 
In order to determine to which factor the weight variations were attributed, the 
composition of multiunit tablets was investigated. The number of micro tablets per 
tablet as a function of the tablet weight is depicted in Figure 3.10.  
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Figure 3.10 Correlation between the number of micro tablets and the weight of the 
multiunit tablet.  
 
A good correlation (R2 = 0.9763) was found between the number of micro tablets 
contained in a tablet and the tablet weight. An increase in tablet weight led to an 
increase in the number of micro tablets. From this linear correlation important 
conclusions can be drawn: 
• The percentage of micro tablet (w/w) based on the tablet weight remained 
constant. Thus, the content of micro tablets subsequently the content of 
theophylline per multiunit tablet was constant during the pilot plant scale. 
• Consequently, any segregation of the mixture occurred during the tableting 
process. 
• Therefore, the weight variations were due to variations in the filling of the die, 
leading to think that the mixtures had poor flow properties.  
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3.3.4 Discussion of the results 
In this section, the influence of the size of single units on the weight variation of 
multiunit tablet was investigated. Ludipress was taken as a reference material due to its 
free-flowing properties. The tableting of Ludipress was then compared to the tableting 
of pellets and micro tablets. The coefficient of variation of the tablet weight and the 
percentage of rejected tablets were used to investigate the production of multiunit 
tablets. The tableting of Ludipress has shown that after an initial phase where the 
powder settled within the feeder, a constant tablet weight was observed. In order to 
produce multiunit tablets, which satisfy the requirements of the European 
Pharmacopoeia with 99 % probability, Altenschmidt and Häusler (1998) have 
demonstrated that the coefficient of variation has to be 2.2 % for tablets having a 
weight of  250 mg in case where the desired weight average corresponds to the actual 
average. In case where the actual weight average deviates from the desired average, 
the limit of the coefficient of variation decreases (Figure 3.8). Considering the 
tableting of pellets in range of 355-425 µm, which has demonstrated a coefficient of 
variation of 1.08 %, a deviation up to 2.9 % of the desired weight average would be 
allowed in order to produce tablets, which meet the European requirements with 99 % 
of probability. Multiunit tablets consisting of pellets in the range of 850 µm to 1700 
µm and micro tablets have showed greater coefficient of variations than 2.2 % and the 
percentage of rejected tablets reached a level of 11.8 % with the coarser pellets. After 
observing that the content of micro tablets per tablet remained constant, it was 
demonstrated that the weight variations were due to variations in the filling of the die, 
leading to think that the mixtures had poor flow properties. 
CHAPTER 4 
FLOWABILITY STUDIES AND TABLETING OF FLOW-OPTIMISED 
FORMULATIONS 
In the previous chapter, it has been observed that the production of multiunit tablets 
consisting of pellets or micro tablets could lead to weight variations outside the 
specifications of the European Pharmacopoeia when the pellet size was above about 
850 µm or when micro tablets of a diameter of 2 mm were used. These weight 
variations were not due to segregation or demixing within the mixture, as the content 
of micro tablets per tablet remained constant and a linear correlation between tablet 
weight and the number of micro tablets per tablet was found. The weight variations 
resulted from the poor flowability of the tableting mass, which led to irregular filling 
of the dies of the tablet press.  
Augsburger and Shangraw (1966) may have been the first to highlight the need to 
determine powder flow for pharmaceutical applications. The flow of solids is involved 
in many pharmaceutical operations such as tableting, encapsulation, blending, 
tumbling, or fluidised bed drying. The critical factor in the tableting of powders is 
often the flow properties of the tableting mass. Uniform tablet weights and uniform 
doses of active ingredients, as well as production rates, are dependent on the ability of 
the solid blend to feed rapidly and in a reproducible manner into the dies. 
Consequently, it appears essential that an accurate assessment of flow properties 
should be done as early as possible in the development process to ensure quality and to 
meet specifications of Pharmacopoeias. 
Many studies are related to the assessment of powder flow. Angle of repose and mass 
flow rate are certainly the more simple and the more widely tests used to determine 
flow characteristics. Some methods are determining flow properties by evaluation of 
packing properties through bulk density determination such as Carr’s compressibility 
index (Carr 1965) or Hausner’s ratio (Hausner 1967). Tan et al. (1990) and Podczeck 
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and Newton (1999) have reported the use of Carr’s compressibility index in predicting 
capsule filling performance. Other methods of predicting powder flow include shear 
cell measurements according to Jenike (Schulze 1995) and the determination of the 
critical orifice diameter. The critical orifice diameter determination has been 
successful to select excipients in the manufacture of micro tablets (Flemming and 
Mielck 1995). More recent sophisticated flow characterisation approaches relate to 
vibrating spatula (Hickey and Concessio 1994) and avalanching methods (Kaye et al. 
1995, Lee et al. 2000). 
In this work, the flow properties of the mixtures were studied with the two following 
methods: the funnel method according to DIN 53916 and a belt conveyor method.  
 
4.1 Determination of flowability according to DIN 53916 
4.1.1 Angle of repose and flow rate 
The angle of repose and the flow rate of the different tableting blends (mixtures 1-6, 
Table 6.7) were investigated using the Pfrengle funnel according to DIN 53 916. The 
time for 150 ml of blend to completely discharge from the funnel was recorded and the 
flow rate was calculated. Table 4.1 depicts the values for the angle of repose and the 
flow rate of the different mixtures. 
Table 4.1 Flow properties of the tableting mixtures containing pellets of different 
sizes and micro tablets in comparison to Ludipress 
Pellets [µm] 
 
Ludipress 
355-425 850-1000 1180-1400 1400-1700 
Micro 
 tablet  
2 mm 
Angle of 
repose [°]  
± S.D 
30.0 
± 0.69 
36.1 
± 0.50 
37.6 
± 0.92 
39.1 
± 0.90 
38.9 
± 0.67 
37.1 
± 0.41  
Flow rate 
[ml/s]        
± S.D 
17.26 
± 2.20 
13.36 
± 1.22 
13.97 
± 0.85 
8.94 
± 1.86 
8.40 
± 1.77 
7.77 
± 1.17 
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As shown in Table 4.1, increasing the single unit size decreases the flowability of the 
mixtures. Ludipress has demonstrated the smallest angle of repose and the highest 
flow rate; that confirms its free-flowing property. For the other blends, the flow was 
designed as difficult according to Devise et al. (1975), as the angle of repose values 
were in a range of 36.1° to 39.1°.  
 
4.1.2 Statistical analysis of the flow rates 
Analysis of variance, also known as ANOVA, is a general method of analysing data 
from experiments, whose objective is to compare two or more means. If only two 
groups are to be compared, a F-test in combination with a t-test can be used to 
compare the means statistically. If more than two groups are to be compared, the 
correct statistical procedure to compare the means is the one-way analysis of variance 
ANOVA (Bolton 1990).  
In order to compare the flow rate means of the different mixtures, a one-way ANOVA 
was carried out. The null hypothesis of equal flow rate means was tested at the 5 % 
level of significance. It was observed that flow rate means of Ludipress, pellets and 
micro tablets mixtures were significantly different (p<0.05); indicating that at least 
two of the flow rate means can be different.  
However, a significant ANOVA test does not immediately reveal which of the 
multiple mixtures tested differ. The question that automatically follows is: Are all 
mixtures different from one another, or are some mixtures not significantly different ? 
In order to solve this question, multiple comparison procedures were undertaken. 
The Newman-Keuls test is a multiple comparison test using the multiple range factor 
Q in a sequential fashion. For routine purposes, the Newman-Keuls method is 
satisfactory (Snedecor and Cochran 1967). In this test, the means to be compared were 
first arranged in order of magnitude. The differences needed for significance for the 
comparison of 2, 3, 4, 5 and 6 means were calculated as: 
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Q*(S2/N)1/2 
where  Q multiple range factor based on the tables of studentised range at 5 % 
level. It depends on the number of means being tested and the degrees of 
freedom of S2 
S2 within mean square in the one-way ANOVA 
N sample size 
 
Considering the flow rate means of the six tableting mixtures (Table 4.1), the 
differences needed for 2, 3, 4, 5 and 6 means to be considered significantly different 
were calculated and are represented as follows:  
 
Number of mixtures 2 3 4 5 6 
Critical difference 3.48 4.21 4.65 4.98 5.21 
 
The results of the Newman-Keuls test for the 6 ordered flow rate means are depicted in 
Table 4.2. Any two means connected by the same underscored line are not 
significantly different. Whereas two means not connected by the underscored line are 
significantly different. 
 
 
Table 4.2 Results of the Newman-Keuls test performed on the flow rate means of 
the mixtures consisting of 60 % (w/w) single units and 40 % (w/w) Avicel 
PH 101. 
Micro Pellets [µm] 
tablet 2 mm 1400-1700 1180-1400 355-425 850-1000 
Ludipress 
7.77 8.40 8.94 13.36 13.97 17.26 
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Newman-Keuls test has revealed that the six mixtures (Table 4.1) were divided into 
two groups significantly different from each other according to flow rate values. In a 
first group were found the coarse single units such as micro tablets, pellets in a range 
of 1400-1700 µm and in a range of 1180-1400 µm. And in the other group were 
included the free-flowing excipient Ludipress and the small pellets (Ø = 850-1000 µm 
and Ø = 355-425 µm). 
 
4.2 Determination of flowability using a conveyor belt 
Taylor et al. (2000) have demonstrated that individual tests failed at some point to 
measure and rank flow properties of powders and that some of the methods could not 
detect small differences in flow between similar materials. This can be partially 
explained by variations in the mechanics of performing the flow tests or the 
interpretation of results. Even though Amidon et al. (1999) have recommended 
procedures for the measurement of flow properties, powder flow cannot be fully 
characterised by one single test methodology. Thus the combination of various tests is 
a better approach to achieve reliable data. 
A conveyor belt was designed to characterise the flow properties of mixtures (see 
Figure 6.7). In the previous section, it was demonstrated that mixtures consisting of 
single units of various sizes were divided into two significantly different groups 
according to flow rates. The conveyor belt recorded the amount of powder blends 
flowing out of the funnel onto a circular belt and carrying the powder to a balance 
(type PM 6100, Mettler Toledo GmbH). The accumulated mass of powder versus time 
was plotted in 0.5-second intervals.  
The speed of the conveyor belt was set at 2.15 cm/s and the gap between the funnel tip 
and the belt was set at exactly 3 mm using a micrometer screw. The gap is a major 
parameter of the conveyor belt that controls the flow of the mixture. When the gap is 
larger than 3 mm, the single units roll out of the belt and when the gap is smaller than 
3 mm, the single units cannot flow freely out of the funnel. Hence, a setup with a gap 
size greater or smaller than 3 mm leads to inaccurate results (see Figure 4.1).  
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Figure 4.1  View of the powder mass accumulated on the moving belt by setting up 
a 2.5 mm-gap between the funnel tip and the belt. 
 
 
Flow properties of Ludipress and the tableting mixtures consisting of 60 % (w/w) 
pellets (mixtures 2,3,4 and 5, Table 6.7) were studied with the conveyor belt for 1 min. 
The mass of powder accumulated on the balance was plotted versus time (Figure 4.2). 
Flow profiles of Ludipress and the tableting mixtures were almost linear within 1 min 
and no plateau was detected. This indicates that the sample was flowing continuously 
out of the funnel. A straight line would have been the representation of an ideal flow 
of material, meaning a constant flow.  
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Figure 4.2 Mass accumulated versus time of Ludipress and tableting mixtures 
consisting of pellets, Avicel PH 101, Kollidon CL, Aerosil 200 and 
magnesium stearate (mixtures 1-5, Table 6.7). (1) Ludipress, (2) pellets 
Ø=850-1000 µm, (3) pellets Ø=355-425 µm, (4) pellets Ø=1180-1400 
µm, (5) pellets Ø=1400-1700 µm 
 
 
In order to compare the flow behaviour of the mixtures, the slopes of the linear 
regressions of mass accumulated versus time curves were calculated. Mean of three 
measurements, standard deviation and coefficient of determination of the linear 
regressions are summarised in Table 4.3. Steeper slopes of mass accumulated 
represent better flow. Ludipress has exhibited the best flow rate and then, in a 
decreasing order, mixtures consisting of pellets 850-1000 µm, pellets 355-425 µm, 
pellets 1180-1400 µm and finally the mixture consisting of the coarser pellets 1400-
1700 µm. A one-way analysis of variance (ANOVA) has revealed that at least two 
means were significantly different (P<0.05). A Newman-Keuls test was performed and 
has demonstrated that Ludipress and every mixture were significantly different from 
one another. The conveyor belt has pointed out more significant differences between 
the mixtures compared to the flow rates measured with Pfrengle’s funnel. 
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Table 4.3 Analysis of mass accumulated curves  
 Ludipress 
Pellets 
355-425 
Pellets 
850-1000 
Pellets 
1180-1400 
Pellets 
1400-1700 
Slope 
± S.D 
0.7372 
± 0.0140 
0.6009 
± 0.0063 
0.6811 
± 0.0065 
0.5232 
± 0.0108 
0.5024 
± 0.0052 
Coefficient of 
determination 
(R2) 
0.9991 0.9992 0.9994 0.9989 0.9994 
 
 
In chapter 3, it has been shown that the compression within 60 min of tablets 
consisting of single units (pellets or micro tablets), Avicel PH 101, Kollidon CL, 
Aerosil and magnesium stearate led to weight variations. The coarser the pellets, the 
greater were the weight variations. The flow properties of two mixtures consisting in 
pellets in a range of 355-425 µm and 1400-1700 µm (mixtures 2 and 5, Table 6.7) 
were investigated for 1 hour with the conveyor belt. The experiment was performed 
three times with each mixture. The mass accumulated of material versus time was 
recorded in 0.5 s-intervals and the slopes were calculated by linear regression. The 
residual plots were computed as the difference between the experimental values and 
the regression values of the mass accumulated. The residual plots are illustrated in 
Figure 4.3.  
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Figure 4.3 Residual plots from mass accumulated of tableting mixture consisting of 
pellets in a range of 355-425 µm (-) and pellets in a range of 1400-
1700 µm (-)(n=3) 
 
A striking difference between the deviations of mass accumulated of mixtures 
containing the small and the coarse pellets was observed. The deviations have reached 
25 g for the pellets in a range of 1400-1700 µm, whereas they have only reached 5 g 
for the pellets in a range of 355-425 µm.  
 
The conveyor belt method was adequate to differentiate flow properties of the 
tableting mixtures. The flow profile represented as the mass of accumulated powder 
versus time was affected by the size of the single units. The bigger the pellets, the 
higher were the variations of flow. The same observation was done regarding the 
weight variations during tableting, leading to confirm that the variations of tablet 
weight during compression are due to flow property of the mixtures.  
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4.3 Characterisation of the mixtures 
A detailed analysis of the composition of the mixtures can explain the negative effect 
of coarse single units (pellets or micro tablets) on the flow properties. For this purpose, 
50.0 g of mixtures consisting of 60 % (w/w) single units (corresponding to 30.0 g) and 
40 % (w/w) Avicel PH 101 (corresponding to 20.0 g) were considered. The number of 
pellets contained in 30 g of pellets and respectively the number of micro tablets 
contained in 30 g of micro tablets were computed. By dividing the bulk volume of the 
mixture by the number of single units contained in it, the volume of one unit: 
pellet/Avicel PH 101, respectively micro tablet/Avicel PH 101, was calculated. A 
schematic representation of one unit pellet/excipient is depicted in Figure 4.4. Finally, 
by subtracting the volume of one pellet (or micro tablet) from the volume of one unit, 
the volume of Avicel PH 101 in one unit can be determined. Table 4.4 shows the 
results of the analysis of the different mixtures in detail. 
 
 
small pellets coarse pellets
one unit pellet/excipient
 
Figure 4.4 Schematic representation of one unit pellet/Avicel PH 101 
as a function of the pellet size 
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Table 4.4 Volumetric analysis of mixtures consisting of pellets or micro tablets and 
Avicel PH 101 [60:40 % (w/w)]  
Pellet or micro tablet sizes [µm] 355- 
425 
850- 
1000 
1180- 
1400 
1400- 
1700 
2000 
Mean diameter [µm] 390 925 1290 1550 2000 
Volume of one single unit [mm3] 3.11*10-2 0.41 1.12 1.95 4.19 
Number of single units in 30 g  631800 47340 17460 10050 4680 
Bulk volume of 50.0 g mixture 
[mm3] 
85667 77667 75667 74333 73333 
Volume of a unit: pellet/Avicel PH 
101 (or micro tablet/Avicel PH 101) 
[mm3] 
0.14 1.64 4.33 7.40 15.67 
Volume of Avicel PH 101 in a unit 
[mm3] 
0.11 1.23 3.21 5.45 11.48 
 
 
The analysis depicted in Table 4.4 has shown that the number of single units contained 
in 1 g of pellets, or micro tablets, was decreased drastically with increasing the single 
unit size. In a mixture consisting of 60 % (w/w) single units, there were 135 times 
more pellets of 390 µm than micro tablets of 2 mm in diameter. Consequently, the 
volume of one unit: pellet/Avicel PH 101 (or micro tablet/Avicel PH 101) has 
increased in a range of 0.14 to 15.67 mm3 with increasing the single unit size in a 
range of 355 µm to 2 mm. Furthermore, the volume of Avicel PH 101 contained in one 
unit has increased from 0.11 mm3 (pellets Ø=390 µm) to 11.48 mm3 (2 mm-micro 
tablets). The bigger the volume of excipient, the bigger is its influence on the flow 
properties of the mixture. Marshall and Sixsmith (1976) have reported in their study 
that Avicel PH 101 has bad flow properties. In addition, Khan and Rhodes (1976) have 
observed that the long-drawn, rod-like shape of Avicel PH 101 particles present a low 
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bulk density, which is certainly responsible for its poor flowability. Thus, the bad flow 
properties of Avicel PH 101 have become more important on the flow properties of 
mixtures containing coarse single units. Moreover, due to the fibrous structure of 
Avicel PH 101 particles, the mixtures form bridges in the filling hopper, which lead to 
a high weight variation of tablets.  
 
4.4 Improvement of the flowability 
In the last two sections (4.1 and 4.2), according to the angle of repose, flow rate and 
conveyor belt results, it was demonstrated that mixtures consisting of single units of 
different sizes and Avicel PH 101 as major excipient present significantly different 
flow properties. The coarser the single units, the worst were the flow properties. 
Moreover, it was observed that the volume of Avicel PH 101 contained in one unit: 
single unit/Avicel PH 101was increased with increasing single unit size. Thus, the bad 
flow properties of the excipient became dominant on the flowability of the mixture. In 
order to reduce the volume of Avicel PH 101 and consequently improve the 
flowability of the mixture consisting of single units of critical size, namely pellets in a 
range of 1400-1700 µm and micro tablets, a coarser microcrystalline cellulose type 
Avicel PH 200 was employed. Avicel PH 200 particles are round aggregates of 
approximately 207 µm in diameter. Flow properties of Avicel PH 200 are better 
compared to fine microcrystalline cellulose powders, due to bigger particle size and 
the round shape of the particles (Muñoz-Ruiz et al. 1994, Doelker et al. 1995, Kibbe 
2000). The properties of Avicel PH 101 and Avicel PH 200 are described in Table 4.5. 
Table 4.5 Properties of different types of microcrystalline cellulose 
Particle size [µm]  
x10 x50 x90 
True density 
[g/cm3] 
Avicel PH 101 
(Lot 6113C) 
19.22 50.09 113.09 1.579 
Avicel PH 200 
(Lot M019C) 
54.39 206.83 489.34 1.552 
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4.4.1 Flowability of Avicel PH 101/Avicel PH 200-mixtures 
Avicel PH 200 and Avicel PH 101 were mixed in various ratios and the flow 
properties of the tableting mixtures consisting either of pellets in a range of 1400-1700 
µm or of micro tablets were measured (Table 4.6 and Table 4.7, respectively).  
 
Table 4.6 Flow properties of tableting mixtures consisting of 60 % pellets 
(Ø=1400-1700 µm), 35.2 % Avicel PH 101/PH 200 in different ratios, 4 
% Kollidon CL, 0.3 % Aerosil and 0.5 % magnesium stearate.  
Avicel PH 101/PH 
200 
100/0 70/30 50/50 30/70 0/100 
Angle of repose [°] 
± S.D 
38.88 
± 0.67 
37.86 
± 0.64 
35.19 
± 0.60 
34.32 
± 0.78 
32.09 
± 0.75 
Flow rate [ml/s] 
± S.D 
8.40 
± 1.77 
8.71 
± 0.26 
8.97 
± 0.37 
11.19 
± 2.57 
13.30 
± 1.06 
 
 
 
Table 4.7 Flow properties of tableting mixtures consisting of 60 % micro tablets 
(Ø=2 mm), 35.2 % Avicel PH 101/PH 200 in different ratios, 4 % 
Kollidon CL, 0.3 % Aerosil and 0.5 % magnesium stearate.  
Avicel PH 101/PH 
200 
100/0 70/30 50/50 30/70 0/100 
Angle of repose [°] 
± S.D 
37.08 
± 0.41 
37.09 
± 0.37 
35.52 
± 0.35 
34.12 
± 0.47 
32.54 
± 0.64 
Flow rate [ml/s] 
± S.D 
7.77 
± 1.17 
7.96 
± 0.07 
9.03 
± 0.36 
9.18 
± 0.35 
10.89 
± 0.19 
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Tableting mixtures containing pellets in a range of 1400-1700 µm have shown a 
decreasing angle of repose from 38.88° to 32.09° with increasing amount of Avicel PH 
200. In addition, the flow rate has increased from 8.40 ml/s to 13.30 ml/s with 
increasing amount of Avicel PH 200. Similar observations were made regarding the 
tableting mixture containing micro tablets; the higher the amount of Avicel PH 200, 
the better was the flow property. Thus, it was concluded that the addition of Avicel PH 
200 could significantly improve the flow properties of tableting mixtures consisting of 
Avicel PH 101 and coarse single units (P<0.05). In a related study, Lahdenpää et al. 
(1996) have investigated the physical characteristics of three Avicel PH grades using a 
mixture design. They found that the flowability of Avicel PH 101 was the poorest, but 
when mixed with the more granular Avicel PH 200, better flow properties were 
achieved. Nevertheless, using only Avicel PH 200 will ensure the best flowing 
properties, but it will also result in poorer bond formation (tablet strength), especially 
with 0.5 % magnesium stearate, as reported by Doelker et al. (1995). Consequently, a 
proportion of the fine Avicel PH 101 has to be retained. Moreover, Avicel PH 101 is 
necessary to ensure a homogeneous single unit distribution within the tablets due to its 
large surface area and a fibrous texture (Wagner 1999). 
 
4.4.2 Influence of the filler type on the tableting of pellets (Ø=1400-1700 µm)  
Multiunit tablets containing pellets in a range of 1400-1700 µm, a mixture of Avicel 
PH 101/PH 200 [30:70 (w/w)], Kollidon CL, Aerosil and magnesium stearate (mixture 
7, Table 6.7) were produced for 60 min on a rotary tablet press (Korsch Pharma 
230/17). A sample of 20 tablets was withdrawn every 3 min during the 60 min 
production time and the tablet weight uniformity was analysed. The average weight of 
all tablets and the 5 % and 10 % limits of tolerance were calculated and the results are 
depicted in Figure 4.5. 
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Figure 4.5 Weight variation of tablets during the compression of 60 % pellets 
Ø=1400-1700 µm, 35.2 % Avicel PH 101/Avicel PH 200 [30:70 (w/w)], 
4 % Kollidon CL, 0.3 % Aerosil, and 0.5 % magnesium stearate 
(mixture 7, Table 6.7). () Average weight, (– –) ± 5 % limit of 
tolerance, () ± 10 % limit of tolerance. 
 
Tablets containing the two types of microcrystalline cellulose, i.e. Avicel PH 101 and 
Avicel PH 200, and pellets in a range of 1400-1700 µm have shown excellent weight 
uniformity within the 60 min tablet production time. Comparing to the same 
experiment performed using the fine Avicel PH 101 as filler alone (Figure 3.5, Chapter 
3), it was observed that the weight variations were reduced from 2.90 % to 1.19 % 
(Table 4.8). Moreover, by using both microcrystalline celluloses, no tablet has 
exceeded the 5 % or the 10 % tolerance limits of the average weight. According to 
Schaafsma and Willemze (1973), the percentage of rejects was less than 0.7 with a 99 
% probability. Lahdenpää et al. (1997) have reported that the weight variations of 
tablets consisting of Avicel PH 101 could be reduced when larger and granular 
particles of Avicel PH 200 are admixed, independently of the compression force in a 
range of 4 to 30 kN. The results of this work support strongly their observations. 
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Table 4.8 Analysis of weight variations of multiunit tablets consisting of pellets in 
a range of 1400-1700 µm and different fillers from a pilot plant 
experiment running over 60 minutes 
 Pellets Ø=1400-1700 µm 
Filler  Avicel PH 101 Avicel PH 101 /Avicel PH 200 [30:70] 
Tablet weight 
average [g] ± S.D. 
0.9514 
± 0.0276 
0.9409 
± 0.0112 
Coefficient of 
variation [%] 2.90 1.19 
Total number of 
tablets produced 24000 24000 
Total number of 
sampled tablets 420 420 
Number of tablets 
above the 5 % 
limits of tolerance 
37 0 
Real percentage of 
rejected tablets*  5.8-11.8 0-0.7 
*According to Schaafsma and Willemze (1973) 
 
4.4.3 Influence of the filler type on the tableting of micro tablets 
Two 30-kg batches of multiunit tablets consisting of micro tablets were compressed on 
a rotary tablet press (Korsch 230/17) for 60 min. The first batch contained Avicel PH 
101 as a filler, while the second batch contained a mixture of Avicel PH 101 and 
Avicel PH 200 in a proportion of 30:70 (w/w) (see mixtures 6 and 8, Table 6.7). In 
order to follow the weight variations during the production time, tablets were 
withdrawn every 3 s using a self-constructed tablet discharge unit (see Figure 6.6). The 
tablets were sampled and stored in the same sequence as they were produced.  
Exactly 1200 tablets were analysed and the tablet weight variation results during the 
compression are depicted in Figure 4.6 and Figure 4.8 depending on the filler 
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employed. Multiunit tablets consisting of micro tablets and Avicel PH 101 as a filler 
have shown great weight variations during 60 min tableting (Figure 4.6). The 
coefficient of variation of the tablet weight was 3.54 % (Table 4.9). From 1200 tablets 
analysed, 155 have exceeded the 5 % limits of tolerance and 10 have exceeded the 10 
% limits of tolerance. Compared to multiunit tablets consisting of micro tablets and a 
mixture of Avicel PH 101/PH 200 [30:70] (w/w) as filler, the coefficient of variation 
was significantly reduced to 1.72 % and only two tablets have exceeded the 5 % limits 
of tolerance (Figure 4.8). According to Altenschmidt and Häusler (1998), the tableting 
of micro tablets and the two types of microcrystalline cellulose will satisfy the 
requirements of the European Pharmacopoeia with 99 % of acceptance probability. 
Furthermore, during the tableting, a deviation of the tablet weight average up to 1.6 % 
of the desired value can occur without failing the requirements (Figure 3.8). 
 
Table 4.9 Analysis of weight variations of 1200 multiunit tablets consisting of 
micro tablets (Ø=2 mm) and different fillers. 
Filler  Avicel PH 101 Avicel PH 101 /Avicel PH 200 [30:70] 
Tablet weight average [g] 
± S.D. 
0.9768 
± 0.0345 
1.0079 
± 0.0174 
Coefficient of variation 
[%] 3.54 1.72 
Number of tablets above 
the limits of tolerance 
5 % 
10 %  
 
155 
10 
 
2 
0 
 
 
Fourier (1822) has shown that it is possible to describe a variable function as a sum of 
infinite sinus functions, which are characterised by amplitude and frequency.  
Thus, the tablet weight variations occurred during the tableting process as a function of 
the time can be characterised by a sum of sinus functions that are defined by an 
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amplitude and a frequency. The weight variation curve and the frequency spectrum are 
two different representations of the same function. A fast Fourier transformation was 
performed on the weight variation curves (Figure 4.6 and Figure 4.8) using the 
program Microcal TM Origin® (Version 6.0). The results of the fast Fourier 
transformation are listed in Table 4.10, and the frequency spectra are depicted in 
Figure 4.7 and Figure 4.9.  
 
Table 4.10 Results of the Fast Fourier Transformation of the weight variation 
curves of tablets consisting of micro tablets and different fillers. 
 Frequency  
[Hz] 
Amplitude Power Interval period 
[min] 
Avicel PH 101 0.00163 117.18 33.77 10:14 
Avicel PH 101 
/Avicel PH 200 
[30:70] 
0.00846 
0.00944 
64.01 
65.58 
10.07 
10.57 
1:58 
1:46 
 
 
If the weight variation curves contain periodic parts, i.e. if the weight variations 
occurred at a constant interval, the amplitudes on the frequency spectrum (Figure 4.7 
and Figure 4.9) will be high. A peak having a high amplitude describes an event that is 
characteristic for the tablet weight variations.  
Considering the frequency spectrum Figure 4.7, a striking peak having an amplitude of 
117 was observed at a frequency of 0.00163 Hz. Thus, the weight variations of 
multiunit tablets consisting of micro tablets and Avicel PH 101 were recurred in an 
interval period of 614 s. The Fourier transform from the weight variations of tablets 
consisting of micro tablets and the two microcrystalline celluloses has revealed two 
peaks at the frequencies of 0.00846 Hz and 0.00944 Hz (Figure 4.9). The amplitude of 
these two peaks is not high enough to say that the variations of tablet weight are 
recurring at intervals of 1:58 min or 1:46 min, respectively.  
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In conclusion, by performing a Fourier transformation, it was observed that the 
compression of tablets consisting of micro tablets and Avicel PH 101 as a filler led to 
weight variations, which recurred periodically, whereas the addition of Avicel PH 200 
to the tableting mixture led to significantly less tablet weight variations, which 
occurred randomly. As it was not possible to correlate these periodical variations with 
any parameters of the machine such as the speed of the rotor or the motor revolutions, 
it can be concluded that the variations were attributed to the tableting mixture. 
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Figure 4.6 Weight variation of tablets during the compression of 60 % micro 
tablets, 35.2 % Avicel PH 101, 4 % Kollidon CL, 0.3 % Aerosil, and 0.5 
% magnesium stearate (mixture 6, Table 6.7). (–) Average weight, (––) 
± 5 % limit of tolerance, () ± 10 % limit of tolerance. 
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Figure 4.7 Fourier transform of weight variation data from Figure 4.6 
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Figure 4.8 Weight variation of tablets during the compression of 60 % micro 
tablets, 35.2 % Avicel PH 101/Avicel PH 200 [30:70], 4 % Kollidon 
CL, 0.3 % Aerosil, and 0.5 % magnesium stearate (mixture 8, Table 
6.7). (–) Average weight, (––) ± 5 % limit of tolerance and () ± 10 % 
limit of tolerance. 
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Figure 4.9 Fourier transform of weight variation data from Figure 4.8 
CHAPTER 5 
PROPERTIES OF TABLETS PREPARED FROM PELLETS AND  
MICRO TABLETS  
During the production of multiple unit dosage forms, the tablets have to meet the 
requirements of Pharmacopoeias and additional specifications in order to ensure a high 
quality. In addition to the uniformity of mass and of content, characteristics of tablets 
such as crushing strength, friability, disintegration time and dissolution have to be 
evaluated. 
 
5.1 Crushing strength and friability 
A tablet requires a certain hardness to withstand mechanical shocks of handling during 
manufacture, packaging and shipping. In addition, by divisible tablets a high crushing 
strength will ensure that the tablets will not break into small pieces. A minimal 
crushing strength of 50 N and a friability value below 1 % will lead to acceptable 
hardness of tablets. 
5.1.1 Influence of the percentage of single units on crushing strength and 
friability of the multiunit tablets 
The crushing strength and friability of multiunit tablets consisting of 60 %, 70 % or 80 
% (w/w) micro tablets and compressed at 150 MPa on a rotary press (Korsch PH 
230/17) were already reported in Table 3.3 (Chapter 3). It was observed that the 
percentage of single units was a major factor influencing the crushing strength. The 
higher the content of micro tablets, the lower the crushing strength was. The crushing 
strength was decreased drastically from 77 N for 60 % micro tablets to 29 N for 80 % 
micro tablets. With a friability of 0.37 %, multiunit tablets consisting of 60 % micro 
tablets met the European Pharmacopoeia requirements. The friability of multiunit 
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tablets composed of 70 % and 80 % micro tablets could not be measured, as the tablets 
were broken after performing the friability test. Beckert (1995) has related the 
decrease of crushing strength to the decrease of excipient quantity, therefore to a 
decrease of contact points between the particles. 
5.1.2 Influence of the single unit size on crushing strength and friability of the 
multiunit tablets 
Multiunit tablets consisting of 60 % (w/w) micro tablets or pellets of 4 different sizes 
were compressed at 150 MPa on the rotary Korsch PH 230/17. The other excipients of 
the tablets were Avicel PH 101 ranging from 35.1 to 35.4 %, 4 % Kollidon CL, 
Aerosil ranging from 0.1 % to 0.4 % and 0.5 % magnesium stearate (mixtures 2-6, 
Table 6.7). Crushing strength and friability of the multiple unit tablets, which were 
described in Table 3.4, are reported in Table 5.1. The bigger the single unit, the lower 
was the crushing strength of the resulting tablets. Pellets in a range of 355-425 µm 
have given very hard tablets with a crushing strength of 200 N, whereas tablets 
consisting of micro tablets had a crushing strength of 77 N. In a mixture consisting of 
60 % (w/w) single units, the number of small pellets is much higher than the number 
of micro tablets (see Table 4.4). Considering the number of particles, it means that 
there are much more points of contact between the different components in a tablet 
formed with small single units than coarse one, hence resulting in higher crushing 
strength values.  
Regarding the friability of the tablets, it was logically observed that a decrease in 
crushing strength has led to an increase in friability. But, according to European 
Pharmacopoeia, the hardness of the multiunit tablets was satisfying. 
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Table 5.1 Influence of single unit size on crushing strength and friability of 
multiunit tablets (formulations 2 to 6, Table 6.7) compressed at 150 MPa  
Single unit Pellets  
355-425 µm 
Pellets  
850-1000 
µm 
Pellets  
1180-1400 
µm 
Pellets  
1400-1700 
µm 
Micro tablets 
2 mm 
Crushing 
strength [N] 
200 164 110 103 77 
Maximal 
value [N] 
267 206 156 151 105 
Minimal 
value [N] 
138 94 60 55 60 
Friability 
[%] 
0.18 0.20 0.20 0.26 0.37 
 
5.1.3 Influence of the type of excipient on crushing strength and friability of the 
multiunit tablets 
In order to study the influence of the type of excipient on crushing strength and 
friability of multiunit tablets, two types of microcrystalline cellulose were used, 
namely Avicel PH 101 and a mixture of Avicel PH 101 and Avicel PH 200 in a 
proportion of 30:70 % (w/w). The composition of the tablets was 60 % single units, 
35.2 filler, 4 % Kollidon CL, 0.3 % Aerosil and 0.5 % magnesium stearate (see 
mixtures 5-8, Table 6.7). The single units were either pellets in a range of 1400-1700 
µm or micro tablets of 2 mm in diameter. The crushing strength and friability of these 
multiunit tablets are presented in Table 5.2. 
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Table 5.2 Influence of excipient type on crushing strength and friability of 
multiunit tablets (formulations 5 to 8, Table 6.7) compressed at 150 MPa 
Single unit Pellets  
1400-1700 
µm 
Pellets  
1400-1700 
µm 
Micro tablets  
2 mm 
Micro tablets 
2 mm 
Filler type Avicel PH 
101 
Avicel PH 
101/PH 200 
[30:70 % 
(w/w)] 
Avicel PH 
101 
Avicel PH 
101/PH 200 
[30:70 % 
(w/w)] 
Crushing strength [N] 103 49 77 74 
Maximal value [N] 151 80 105 102 
Minimal value [N] 55 28 60 47 
Friability [%] 0.26 0.71 0.37 0.40 
 
 
According to the results of Table 5.2, the excipient type had a striking influence on the 
crushing strength and the friability of multiunit tablets consisting of pellets in a range 
of 1400-1700 µm. Tablets containing Avicel PH 101 alone were strong, whereas the 
addition of Avicel PH 200 has led to weaker tablets. Tablets obtained with the mixture 
of the fine and the coarse Avicel were too weak according to the minimal value of the 
crushing strength. Ladhenpää et al. (1997) have reported that the particle size and 
density parameters were the most important factors influencing the crushing strength 
of tablets prepared from Avicel of different grades. 
Unlike tablets made of pellets in a range of 1400-1700 µm, the crushing strength and 
the friability of tablets consisting of micro tablets did not seem to be influenced by the 
type of excipient. This observation can be explained by the hardness of the micro 
tablets, which is greater compared to the hardness of pellets. It seems in case of the 
micro tablets that the crushing strength is conferred by the micro tablets themselves 
and less by the number of particles, which is the case for the multiunit tablets 
consisting of pellets.  
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5.2 Disintegration time 
According to the European Pharmacopoeia 4th edition, uncoated tablets have to 
disintegrate in water within 15 min to comply with the test. Consequently, transposed 
to multiunit tablets, it means that single units have to be separated from the excipients 
within 15 min.  
5.2.1 Influence of the single unit size on the disintegration time of the multiunit 
tablets 
Multiunit tablets consisting of 60 % (w/w) single units were compressed at 150 MPa 
on a rotary press. The other components of the tablets were Avicel PH 101 in a range 
of 35.1 to 35.4 %, 4% Kollidon CL, Aerosil in range of 0.1 % to 0.4 % and 0.5 % 
magnesium stearate (mixtures 2-6, Table 6.7). Kollidon CL, a cross-linked povidone, 
acts as tablet disintegrant. It is generally used at a 2 to 5 % concentration (Gordon et 
al. 1987, Gordon et al. 1993). Table 5.3 reports the disintegration time of tablets 
consisting of 4 sizes of pellets (355-425 µm, 850-100 µm, 1180-1400 µm and 1400-
1700 µm) and micro tablets (2 mm). All multiunit tablets have shown a disintegration 
time within 15 min. But the disintegration time was highly influenced by the size of 
the single units. Tablets consisting of pellets in a range of 355–425 µm had a 
disintegration time of 14 min, whereas tablets from micro tablets compressed at the 
same compression force have disintegrated within 13 s. Nevertheless, by tableting 
pellets in a range of 355-425 µm at a lower compression force, it is possible to reduce 
the disintegration time. Regarding the crushing strength and disintegration time, it was 
not surprising to find a correlation; the higher the crushing strength, the higher was the 
disintegration time. 
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Table 5.3 Influence of the single unit size on the disintegration time of 
multiunit tablets 
Single unit Pellets  
355-425 
µm 
Pellets  
850-1000 
µm 
Pellets  
1180-1400 
µm 
Pellets  
1400-1700 
µm 
Micro tablets 
2 mm 
Disintegration 
time  
14 min 3 min 11 s 35 s 31 s 13 s  
 
5.2.2 Influence of the type of excipient on the disintegration time of the multiunit 
tablets 
The influence of the type of excipient on the disintegration time of multiunit tablets 
was investigated. The mixtures consisting of 60 % single units, 35.2 % filler, 4 % 
Kollidon CL, 0.3 % Aerosil and 0.5 magnesium stearate were compressed at 150 MPa 
on a rotary tablet press (mixtures 5-8, Table 6.7). The filler was either Avicel PH 101 
or a mixture of Avicel PH 101/PH 200 in a proportion 30:70 % (w/w). Tablet 
disintegration time has shown a similar dependence on the type of excipient as the 
tablet crushing strength. The disintegration time of tablets made of pellets in a range of 
1400-1700 µm was really affected by the type of excipient. Ladhenpää et al. (1997) 
have reported that the disintegration of microcrystalline cellulose tablets was attributed 
to the penetration of hydrophilic liquid into the tablet matrix by means of capillary 
pores and the subsequent breaking of the hydrogen bonding between cellulose 
microcrystals. Small, fibrous particles of Avicel PH 101 pack densely and have a large 
bonding area with relatively small interparticular pores. The addition of large and 
granular Avicel PH 200 results in large interparticular pores. Water can easily reach 
the hydrogen bonds between cellulose microcrystals and can cause their breaking and 
thus rapid disintegration of tablets.  
Unlike tablets made of pellets in a range of 1400-1700 µm, the type of excipient did 
not affect the disintegration time of tablets made of micro tablets. The disintegration 
time values were not significantly different. These tablets have disintegrated rapidly in 
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water in about 13 s, which is again in good agreement with the hardness values of 
these tablets.  
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Figure 5.1 Influence of the type of excipient on the disintegration time of multiunit 
tablets 
 
 
5.3 Dissolution 
Theophylline micro tablets based on an Eudragit RS PO matrix, which delivered the 
drug within 8 hours, were compressed on a rotary tablet press (Kilian TX 40) at a 
compaction pressure of 200 MPa. Rey et al. (2000) have described in detail the 
production of such micro tablets. The micro tablets were composed of 98 % 
theophylline granules and 2 % magnesium stearate whereas theophylline granules 
consisted of 70 % theophylline, 12 % Eudragit RS PO, 12 % magnesium stearate and 6 
% Eudragit RS 30 D (with 10 % TEC as plasticizer) (see section 6.4). Drug release 
profiles were carried out using a paddle apparatus Sotax AT7 at a rotational speed of 
50 rpm. The dissolution medium was 900 ml maintained at 37 °C. The different 
mediums tested were purified water, 0.1 N HCl, phosphate buffer with Triton X100 
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adjusted to pH 4.5 and phosphate buffer at a pH 3.0 during 3.5 h followed by pH 7.4. 
The two phosphate buffers are described in USP 25 under “theophylline extended-
release capsules” tests 4 and 7 respectively. The influence of the dissolution medium 
on the theophylline release from micro tablets within an 8-h period was investigated 
(Figure 5.2).  
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Figure 5.2 Influence of the dissolution medium on theophylline release from micro 
tablets based on a Eudragit RS PO-matrix (n=3). (-) purified water, () 
pH 4.5 phosphate buffer, () pH 3.0 phosphate buffer during 3.5 h and 
pH 7.4, () 0.1N HCl. Error bars represent the 95 % confidence 
interval. 
 
After 8 hours, the micro tablets were still present in the dissolution vessels. The 
dissolution medium has shown no significant effect on the drug release from micro 
tablets based on an Eudragit RS PO matrix as dissolution rates were quite similar. 
Consequently, further dissolution tests were performed in purified water. 
 
After the compression of multiunit tablets, it is important that the single units held 
their release characteristics. Several studies have already reported that damages of 
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coated units during the compression into multiunit tablets were responsible for a 
significant increase of the drug release (Béchard et Leroux 1992, Lehmann et al. 1993, 
Beckert et al. 1996). Matrix tablets present the advantage over coated forms that the 
release of drug is not dependent on the change of the film coating after the compaction 
process. 
Multiunit tablets composed of matrix micro tablets in a range of 60 % to 70 % (w/w), 
Avicel PH 101 in a range of 25.2-35.2 %, 4 % Kollidon CL, 0.3 % Aerosil and 0.5 % 
magnesium stearate were then compressed at 150 MPa on a Korsch PH 230/17. The 
dissolution test was carried out in 900 ml purified water at a rotational speed of 50 
rpm. Theophylline profiles of micro tablets and multiunit tablets consisting of the 
same micro tablets were compared (Figure 5.3). Multiunit tablets were also tested for 
compliance with the specifications of USP 25 Drug release test 7. The limits of 
tolerance of the dissolution rates are listed in Table 5.4. According to the dissolution 
profiles, it was observed that the release of theophylline from multiunit tablets and 
micro tablets was similar. Thus, the compression from micro tablets into multiunit 
tablets did not influence the subsequent drug release. Moreover, the content of micro 
tablets in a range of 60-70 % did not affect the release. In addition, it was observed 
that multiunit dosage forms have fulfilled the requirements of USP 25 for 
theophylline-release preparations as the dissolution rates were found within the 
tolerance limits.  
 
Table 5.4 Tolerance limits for dissolution rates according to USP 25 drug release 
test 7 
Time (h) Amount dissolved 
1 between 10 % and 40 % 
2 between 35 % and 70 % 
4 between 60 % and 90 % 
8 not less than 85 % 
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Figure 5.3 Theophylline release from micro tablets (-) and from multiunit tablets 
containing 60 % (w/w) micro tablets () and 70 % micro tablets () in 
purified water. (- -) Tolerance limits of USP 25 Test 7. Error bars 
represent the 95 % confidence interval. 
 
CHAPTER 6 
MATERIALS AND METHODS 
6.1 Materials 
Table 6.1 Excipients and chemicals 
Name Batch Manufacturer / supplier 
Aerosil 200 S326030 Degussa AG 
Avicel PH 101 6629C /6050C / 6113C FMC Corp./ Lehmann & Voss & Co. 
Avicel PH 200 M019C FMC Corp./ Lehmann & Voss & Co. 
Eudragit RS PO 0460738073 Röhm GmbH & Co. KG 
Eudragit RS 30 D 0480318065 Röhm GmbH & Co. KG 
Hydrochloric acid 37 % 113386 Merck KGaA 
Kollidon CL 87_0817 / 36_0185 BASF AG 
Ludipress 62_1227 BASF AG 
Magnesium stearate 190151 Bärlocher GmbH 
Monobasic potassium 
phosphate A127771918 Merck KGaA 
Pellets, neutral 1400-1700 B 08650842 Hanns G. Werner GmbH 
Phosphoric acid 85 % K3673775 Merck KGaA 
Sodium hydroxide B118598 Merck KGaA 
StarLac L0126 Meggle GmbH 
Suglets 355-425 104F NP Pharm S.A 
Suglets 850-1000 106E NP Pharm S.A 
Suglets 1180-1400 909T NP Pharm S.A 
Theophylline, anhydrous, 
powder 200 346954 Abbott GmbH & Co. KG 
Triethyl citrate N7Y190-H813066M Röhm GmbH & Co. KG 
Triton X100 45274 Fluka 
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6.2 General equipment 
Table 6.2 List of general equipment 
Equipment Manufacturer / supplier 
Balance Mettler AE 200 Mettler Toledo GmbH 
Balance Mettler PC 1616 Mettler Toledo GmbH 
Balance Mettler PM 6100 Mettler Toledo GmbH 
Gyro-wheel mixer Self-constructed 
Stirrer, IKA Combimag RCH Janke & Kunkel 
Turbula-mixer T2C Bachofen 
Ultra-Turrax T25 Janke & Kunkel 
UV-Vis spectrophotometer 550S Perkin-Elmer GmbH 
6.3 Data processing 
Computer: Pentium III 733 MHz, 512 MB RAM, 20 GB hard disk. 
Table 6.3 List of softwares 
Software Manufacturer / supplier 
Compression Research System Korsch Pressen GmbH 
Mastersizer 2000 version 4.0 Malvern 
Microcal ™ Origin version 6.0 Microcal Software 
Microsoft DOS 2.2 and 6.22 Microsoft 
Microsoft Excel 2000 Microsoft 
Microsoft Power Point 2000 Microsoft 
Microsoft Word 2000 Microsoft 
VCH Biblio for Windows VCH publishing society 
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6.4 Preparation of the micro tablets 
6.4.1 Granulation 
2800 g of theophylline powder, 480 g of Eudragit RS PO and 480 g of magnesium 
stearate were mixed in a fluidised bed granulator (WSG 5, Glatt GmbH) for 10 min. 
Afterwards the mixture was granulated by top spraying 4000 g of an aqueous 
dispersion consisting of Eudragit RS 30 D as a binder and triethyl citrate as a 
plasticizer. The aqueous granulating dispersion was prepared by dissolving 24 g of 
triethyl citrate in 3176 g of water under agitation using an Ultra-Turrax homogeniser 
for 10 min (Ultra-Turrax T25, Janke & Kunkel). The solution was then added into 800 
g of the polymer dispersion with continuous stirring (Stirrer IKA Combimag RCH, 
Janke & Kunkel). The spray dispersion was supplied by a peristaltic pump (Watson 
Marlow 505S) and was stirred throughout the spraying process. The composition of 
the granules and the granulating parameters are listed in Table 6.4. 
 
 
Table 6.4 Description and preparation of theophylline granules 
Products Amount [g] Dry substance [g] 
Theophylline, anhydrous, powder 200  2800.0 2800.0 
Eudragit RS PO  480.0 480.0 
Magnesium stearate  480.0 480.0 
Eudragit RS 30 D  800.0 240.0 
Triethyl citrate  24.0 24.0 
Water  3176.0  
Total  7760.0 4024.0 
Solids content of the spray dispersion [w/w]  6.6 %  
Equipment WSG 5  
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Spray nozzle diameter [mm] 1.8  
Batch [g] 3760.0  
Spray suspension [g]  4000.0  
Preheating time [min] 7  
Spraying time [min] 33  
Inlet air temperature [°C] 65  
Outlet air temperature [°C] 30  
Atomizing air pressure [bar] 2.5  
Suspension flow rate [g/min] 121.2  
Drying time [min] 25  
 
The dried granules were sieved by hand and fractions below 500 µm were taken for 
compression of micro tablets (Flemming and Mielck 1995). 
 
6.4.2 Composition of the micro tablets 
Micro tablets containing theophylline and StarLac respectively were prepared. The 
composition of theophylline micro tablets and the StarLac containing micro tablets is 
given in Table 6.5. Theophylline micro tablets were produced from theophylline 
granules as described under section 6.4.1. 
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Table 6.5 Composition of the micro tablets in % (w/w) 
 Theophylline micro tablets Placebo micro tablets 
Theophylline granules 98 - 
StarLac - 99 
Magnesium stearate 2 1 
Batch size 20 kg 36 kg 
 
6.4.3 Blending 
Theophylline granules were blended with 2 % magnesium stearate in a laboratory 
blender (type 951922, Servolift GmbH) for 20 min. Magnesium stearate was passed 
through sieve No. 5 (mesh size 0.315 mm) before mixing. 
3 batches of 12 kg from StarLac and 1 % magnesium stearate were blended for 20 min 
at 40 rpm in a self-constructed gyro-wheel mixer using a steel drum (∅ = 40 cm, h = 
45 cm). Magnesium stearate was passed through sieve No. 5 (mesh size 0.315 mm) 
before mixing. The three batches were combined for tableting.  
 
6.4.4 Tableting of the micro tablets 
Rotary tablet press Korsch Pharma 230/17 
The rotary tablet press Korsch Pharma 230/17 (Korsch Pressen GmbH) is a modern 
medium-range machine with 17 pairs of punches and production rates between 25 000 
and 125 000 tablets per hour. The tablet machine was fitted with 2*4 strain gauges 
(type HBM 6/120 LY 11, Hottinger Baldwin Messtechnik GmbH) that were placed in 
a full-bridge configuration on the upper and lower holders of the main rollers. The 
construction principle and the instrumentation of the tablet machine have been 
described by Vogel (1992).  
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Calibration 
The calibration of the compression force at the upper and lower roller holders was 
performed according to Leitriz et al. (1995) with a piezo-electric transducer (type 
9021A, Kistler Instruments GmbH) and a charge amplifier (Type 5007, Kistler 
Instruments GmbH). The acquisition of the data was performed using a MGC Plus 
system as described by Dressler (2002). The sensitivity of the carrier frequency bridge 
amplifier was set at 1 mV/V. The calibration chain is depicted in Figure 6.1. 
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Figure 6.1  Static calibration of compression force  
 
Six different compression levels (2, 5, 10, 15, 20 and 25 kN) were employed for the 
calibration of the compression force. The levels were adjusted by varying the band 
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height from 2.2 mm to 1.5 mm). The measurements were repeated 6 times for each 
compression level. Linear regression (Sachs 1997, Schmidt 1997) and analysis 
function (Leitritz et al. 1995) were calculated. Calibration factors resulting from the 
analysis function were stored in the CRS software (Korsch Pressen GmbH). The 
results of the calibration are illustrated in Table 6.6. 
Table 6.6 Results of the static calibration of compression force 
Parameter Upper punch Lower punch 
Number of calibration points 36 36 
Degrees of freedom  34 34 
Significance level  95 % 95 % 
Slope  0.1377 0.2442 
Intercept  -0.1778 -0.0408 
Variance in y 0.0007 0.0007 
Variance of slope 3.00*10-7 2.87*10-7 
Variance of intercept 7.18*10-5 6.94*10-5 
Correlation coefficient  0.9997 0.9999 
Coefficient of determination 0.9994 0.9998 
Regression function y = 0.1377*x-0.1778 y = 0.2442*x-0.0408 
Regression function through the  
origin y = 0.128*x y = 0.242*x 
Analysis function through the 
origin 
x = 7.8125*y x = 4.1322*y 
 
Figure 6.2 and Figure 6.3 illustrate the calibration curves of the upper and lower 
punches with 95 % confidence interval. The confidence interval was magnified ten 
times for a better visualisation. The residual plots of the calibration are depicted in 
Figure 6.4 and Figure 6.5.  
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Figure 6.2  Calibration curve of the upper punch and its 95 % confidence interval 
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Figure 6.3  Calibration curve of the lower punch and its 95 % confidence interval 
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Figure 6.4  Residual plots of the upper punch calibration 
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Figure 6.5  Residual plots of the lower punch calibration 
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Tableting of micro tablets 
Theophylline micro tablets were compressed on an instrumented rotary tablet press 
(Kilian TX 40, Kilian & Co. GmbH)1 and StarLac containing micro tablets were 
compressed on an instrumented Korsch Pharma 230/17 (Korsch Pressen GmbH) fitted 
with a force feeder. The Korsch Pharma Press was equipped with one pair of punches 
each containing 19 small concave punches of a diameter of 2 mm (Ritter Pharma-
Technik GmbH). The speed of the tablet machine was kept constant at 50 rpm. A band 
height of the micro tablets of 0.8 mm and a compaction pressure of 200 MPa were 
employed.  
Data acquisition and processing were performed by the Compression Research 
System CRS (Korsch Pressen GmbH). The system was switched on 30 min before the 
beginning of the compression, the amplifiers were controlled and the strain gauges 
were adjusted. The compression forces at the lower and upper punches were checked 
on an oscilloscope and the values were saved every 15 min. 
                                                 
1
 We gratefully acknowledge Abbott GmbH & Co. KG, Germany, for compressing the theophylline micro 
tablets. 
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6.5 Tableting of pellets and micro tablets into multiunit tablets under pilot 
plant conditions 
6.5.1 Composition of pilot plant tableting mixtures 
The compositions of the various 30 kg-batches are described in Table 6.7.  
 
Table 6.7 Composition of 30 kg- tableting mixtures in % (w/w) 
Mixtures  
Ingredients 1 2 3 4 5 6 7 8 
Ludipress 99.5        
Pellets [µm]         
355-425  60       
850-1000   60      
1180-1400    60     
1400-1700     60  60  
Micro tablets      60  60 
Avicel PH 101  35.1 35.4 35.2 35.2 35.2 10.56 10.56 
Avicel PH 200       24.64 24.64 
Kollidon CL  4 4 4 4 4 4 4 
Aerosil  0.4 0.1 0.3 0.3 0.3 0.3 0.3 
Magnesium 
stearate 
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
 
6.5.2 Blending of pilot plant tableting mixtures 
The ingredients of each mixture (Table 6.7) consisting of 3*10 kg-batches were 
blended without magnesium stearate in a gyro-wheel mixer using a stainless steel 
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drum for 20 min. The mixing speed was set at 40 rpm. The lubricant was passed 
through sieve No. 5 (mesh size 0.315 mm) and mixed with the mixtures for additional 
10 min. The three batches were combined for tableting. 
 
6.5.3 Tableting of pilot plant batches 
Multiunit tablets were compressed on an instrumented rotary tablet press (Korsch 
Pharma 230/17, Korsch Pressen GmbH) using a gravity feeder (Art. No 8590052, 
Korsch Pressen GmbH). The description and the calibration of the tablet press were 
described under section 6.4.4. Eight of the 17 punch stations were equipped with 13 
mm round flat-faced punches of type B (Ritter Pharma-Technik GmbH). The speed 
level and the compression force were set at 50 rpm and 150 MPa, respectively, thus a 
tableting time of 1 hour resulted. The filling depth and the band height were adjusted 
at the beginning and were kept constant during tableting. During tablet compression, a 
minimum material level in the filling hopper was maintained by hand in order to avoid 
weight variations due to fluctuation of the material level.  
A tablet discharge (Figure 6.6) was used in order to collect tablets every 3 s. The 
tablet discharge was equipped with a rotary magnet type D52-LOR-N (Kuhnke 
GmbH) and a self-constructed metal shunting device that were fastened via two guide 
rails with snap mechanism. The rejected tablets were guided to the corresponding rail 
by means of the rotary magnet and the shunting device. The magnet was supplied with 
current and the activation of the magnet was performed using a MS-DOS 6.22 
programme (Microsoft GmbH). 
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Figure 6.6 Schematic diagram of the tablet discharge and the shunting device 
 
Data acquisition and processing were performed by the Compression Research 
System CRS (Korsch Pressen GmbH). The system was switched on 30 min before the 
beginning of the compression, the amplifiers were controlled and the strain gauges 
were adjusted. The compression forces at the lower and upper punches were checked 
on an oscilloscope and the values were saved every 15 min. 
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6.6 Analytical methods 
6.6.1 Powder analysis 
Bulk and tapped density 
50.0 g of each substance (m) to be examined were introduced without compacting into 
a 250 ml graduated cylinder using a powder funnel. The unsettled volume (V0) was 
read and the bulk density [g/ml] was calculated as the quotient m/V0 according to the 
“Deutsche Industrie Standard” DIN 53912. Measurements were performed in 
triplicate and the mean value was calculated. 
An Engelsmann tap meter (JET ST 2, Engelsmann AG) was used to measure the 
tapped density according to DIN 53194. 1250 taps were carried out and the 
corresponding volume (V1250) was recorded. Measurements were performed for each 
substance in triplicate and the mean value was calculated. The tapped density [g/ml] is 
expressed as the quotient m/V1250.  
The Hausner factor was calculated as the ratio of tapped and bulk density of the 
powders. Hausner factor values < 1.25 indicate good flow properties whereas values > 
1.25 exhibit poor flow properties (Hausner 1967).
 
True density 
The true density was determined using a Beckman air comparison pycnometer (Model 
930, Beckman Instruments Inc.) at room temperature. Micro tablets and pellets were 
first ground with a mortar and pestle for ten minutes and an amount of material 
representing 80 % (v/v) of the sample cup was exactly weighed (Mettler AE 200, 
Mettler Toledo GmbH).  The zero measurement and the starting number (108.05) 
were checked before measurements according to the machine’s operating procedure. 
True density was calculated as the quotient of weighed substance to true volume. The 
mean value of three measurements was determined.  
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Particle size 
The particle size distribution of 20 g of theophylline granules was measured by a 
Sympatec-HELOS laser diffraction spectrometer KA Compact (Sympatec GmbH). 
The gravity-dispersing system GRADIS, a focal length of 500 mm and a measuring 
time of 10 s were employed. A reference measurement without powder was performed 
before each sample. Data acquisition and analysis were performed using the software 
HELOS (version 4.6.58, Sympatec GmbH) on a HP Vectra M2 4/66 computer. The 
mean value of three measurements was taken. 
The particle size distributions of Avicel PH 101, Avicel PH 200, Ludipress and the 
pellets (Ø=355-425 µm, Ø=850-1000 µm, Ø=1180-1400 µm) were measured by laser 
diffraction spectrometer Mastersizer 2000 (Malvern Instruments GmbH) using the 
dry-dispersing system Scirocco 2000 (Malvern Instruments GmbH). The dispersing 
air pressure was set at 1 bar for Ludipress and the pellets and at 3 bar for Avicel PH 
101 and Avicel PH 200. Data were directly supplied by means of software (Malvern 
Instruments GmbH). A reference measurement without powder was performed during 
10 s before each sample. The mean value of three measurements of 10 s was 
calculated.  
Angle of repose and flow rate 
The angle of repose was measured using a Pfrengle funnel according to DIN 53916. 
150 ml of material were flowing through a 10 mm-orifice funnel on a disc of a radius 
(r) of 50 mm. The distance between the aperture of the funnel and the disc was 75 
mm. The height (h) of the powder cone was measured and the angle of repose () was 
calculated using the following equation: tan  = h/r. The mean value of five samples 
was taken. 
The flow rate [ml/s] was defined as the time needed for a defined volume of material 
to flow out of the funnel. The mean value of five samples was calculated. 
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Flowability using a conveyor belt 
A new method was designed to measure the flowability of the different mixtures using 
a conveyor belt. The setup of this method is shown in Figure 6.7 and Figure 6.8. The 
conveyor belt consists of a circular strip of plastic material of 77 cm in length and 10 
cm in width (Reiff-Technische Produkte GmbH). The belt rotates at a speed of 2.15 
cm/s (motor type 3557K024CR, Dr. F. Faulhaber GmbH). Mixtures are passed 
through the funnel to the belt and conveyed to a balance (type PM 6100, Mettler 
Toledo GmbH). The dimensions of the funnel are listed in Table 6.8. The gap between 
the funnel and the belt was set to 3 mm using a micrometer (0.01 mm, Mitutoyo 
Messgeräte GmbH). The weight of the powders conveyed was recorded every 0.5 s 
and cumulative as well as differential curves were plotted automatically (HP VEE 
Program, version 5.0). Mixtures 1, 3, 4 and 7 (Table 6.7) were investigated for 1 min 
and mixtures 2 and 5 (Table 6.7) were investigated for 1 min and 60 min. All 
measurements were repeated 3 times.  
 
 
Table 6.8 Dimensions of the funnel [cm] 
Diameter of the funnel 7.9 
Diameter of the orifice 1.9 
Total height of the funnel 14.5 
Height of the upper vertical part 5.8 
Height of the lower conical part 5.7 
Height of the orifice 3 
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Figure 6. 7  Setup of the conveyor belt  
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Figure 6.8 Schematic diagram of the conveyor belt 
84  6 MATERIALS AND METHODS 
6.6.2 Physical characterisation of the tablets 
The following characteristics of the tablets were determined 24 hours after tableting. 
Tablet mass 
The tablet mass was determined on an analytical balance (AE 200, Mettler Toledo 
GmbH). Mean, standard deviation and coefficient of variation were calculated. 
Crushing strength 
The crushing strength of the micro tablets was determined according to the European 
Pharmacopoeia 2002 (2.9.8 “Resistance to crushing of tablets”) using a crushing 
strength tester Model 6D (Dr. Schleuniger Pharmatron AG). The crushing strength of 
the multiunit tablets was investigated using a crushing strength tester TBH 30 
(Erweka GmbH). Tablet fragments were removed from the jaws before the next 
measurement. Mean, standard deviation and coefficient of variation were calculated. 
Disintegration time 
The disintegration test was performed according to the European Pharmacopoeia 2002 
(2.9.1 “Disintegration of tablets and capsules”) using a disintegration tester type PTZ 
1 (Pharmatest Apparatebau). A 1-liter beaker was used and the temperature of the 
water was maintained at 36-38 °C. The disintegration time was defined as the time 
required for the pellets or the micro tablets of 6 multiunit tablets to be totally 
separated from the excipients. The mean value of three determinations was calculated. 
Friability 
The tablet friability was determined according to the European Pharmacopoeia 2002 
(2.9.7 “Friability of uncoated tablets”). 10 tablets were tested using a friability tester 
type PTF1 (Pharmatest Apparatebau) for 4 min at 25 rpm. Loose dust particles were 
removed from the tablets with air pressure before and after the test. The tablet 
friability was calculated from the loss of mass and expressed as the percentage of the 
initial mass. 
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6.6.3 UV-spectrophotometry 
Spectrophotometer 
Ultraviolet (UV) spectrophotometer  550S (Perkin-Elmer GmbH) 
Cuvette 1 cm quartz cuvette, volume 2.5 ml 
 
All theophylline samples were measured in increasing order. The cuvette was rinsed 
with about 3 ml of the sample before each measurement. Dilutions were carried out by 
means of Eppendorf Research 1000 pipette (Eppendorf AG) if the measured 
absorption was more than 0.8. 
Calibration 
The UV-absorption spectrum of theophylline between 200 and 400 nm in purified 
water was measured in order to determine the maximum absorption wavelength 
(scanning speed 60 nm/min).  
Linearity 
19.9 mg of theophylline were dissolved in purified water in a 500 ml volumetric flask 
(stock solution). 5, 10, 15, 20, 25, 30 and 35 ml from the stock solution were diluted 
to 100 ml using purified water. The samples were measured 6 times at 271.2 nm and a 
linear regression was calculated. The results are summarized in Table 6.9. 
Reproducibility  
In order to test the reproducibility of the method, a sample was measured 6 times. The 
mean value and the coefficient of variation were calculated (Table 6.10). 
Recovery 
580 mg of micro tablets containing 68.5 % (w/w) theophylline were homogenised for 
20 min using an Ultra-Turrax (Janke & Kunkel) in 500 ml purified water 
(corresponding to a nominal theophylline content of 79.46 mg/100 ml). 9.0 ml of the 
homogenised solution was diluted to 10.0 ml using purified water. And 99.0 ml of the 
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homogenised solution were diluted to 100.0 ml using a standard solution containing 
800 mg theophylline in 100 ml purified water. The resulting solutions contained 
between 90.0 % and 109.1 % of theophylline, based on the nominal content. The 
mean value of three measurements was calculated and the results are presented in 
Table 6.10. 
 
Table 6.9 Data of the calibration of theophylline 
Parameter Theophylline 
Measuring range [mg/100 ml] 0.199-1.393 
Number of measurements 42 
Correlation coefficient 0.9999 
Slope 0.5817 
Standard deviation (slope) 9.52 * 10-4 
Intercept - 0.0045 
Linear regression f(x) = 0.5817 * x - 0.0045 
 
Table 6.10 Statistical data of the validation of the UV-method 
Parameter Concentration 
of theophylline 
[mg/100 ml] 
Percent of the 
nominal content 
[%] 
Recovery rate 
[%] 
Coefficient of 
variation [%] 
Reproducibility 0.597   0.16 
Recovery 71.514 90.0 99.58 0.45 
 79.460 100.0 100.56 0.42 
 86.665 109.1 99.32 0.49 
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Theophylline content 
Micro tablets  
Ten micro tablets were ground using a mortar and pestle for ten minutes and dispersed 
with purified water in a 100-ml volumetric flask. After dilution and filtration (glass 
fibre filter, type 13400-25-S, Sartorius AG), the theophylline content was assayed 
using an UV-spectrophotometer (Perkin Elmer 550S, Perkin-Elmer GmbH) at 271.2 
nm. Each sample was measured three times. 
Multiunit tablets  
One multiunit tablet was ground using a mortar and pestle for ten minutes and 
dispersed with purified water in 1000-ml volumetric flask. After dilution and filtration 
(glass fibre filter type, 13400-25-S, Sartorius AG), the theophylline content was 
assayed using an UV-spectrophotometer (Perkin Elmer 550S, Perkin-Elmer GmbH) at 
271.2 nm. Each sample was measured three times. 
 
Dissolution test 
Drug release profiles of the tablets were determined using a paddle dissolution 
apparatus (dissolution-tester Sotax AT7, Sotax AG) with the following equipments: 
Pump piston pump CY 7-50 
Collector fraction collector C 613 
Software DOS-version 2.2 
Hardware IBM, type AT, 1 MB memory, 80 MB hard disk 
Interface Type PA 29A 
Filter glass fibre (type 13400-25-S, Sartorius AG) 
 
Before the collection of each sample, 10 ml of the dissolution medium were pumped 
in order to compensate the dead volume of the flexible tube. 
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The dissolution tests were carried out with 300 mg of micro tablets or one multiunit 
tablet per dissolution vessel. 900 ml of dissolution medium were used and maintained 
at 37 °C  0.5. Purified water was used for the dissolution of multiunit tablets, 
whereas purified water, 0.1 N HCl and phosphate buffers according to test 4 and test 7 
of the USP 25 “theophylline extended-release capsules” were the mediums for the 
dissolution of micro tablets. Aliquots of 5-ml were taken automatically at specified 
time intervals: 15, 30, 60, 120, 180, 240, 300, 360, 420 and 480 min. During 
sampling, the removed volume was not replaced. The rotational speed of the paddles 
was set at 50 rpm. At the end of the dissolution test, the content of the vessels was 
homogenised for 10 min using an Ultra-Turrax T25 (Janke & Kunkle) and the 
solutions were filtrated through a glass fibre filter (type 13400-25-S, Sartorius AG). 
The total theophylline content was assayed using an UV-spectrophotometer (Perkin 
Elmer 550S, Perkin-Elmer GmbH) at 271.2 nm. The sum of all samples analysed plus 
the content of theophylline remaining in the vessel was considered as the 100 %-
value. Results are expressed as a percent of the 100 %-value. 
CHAPTER 7 
CONCLUSION 
In the present work, the production of multiunit tablets containing pellets or micro 
tablets under pilot plant conditions was described. Nowadays, the development of 
multiparticulate systems has gained a lot of interest, as they have demonstrated several 
advantages over conventional single-unit formulations: less risk of dose-dumping, less 
inter and intra-subject variability, higher degree of dispersion in the gastro-intestinal 
tract thus minimizing irritation due to high local drug concentrations. Multiunit tablets 
combine the advantages of multiunit systems with those of tablets, i.e. cost 
effectiveness and divisibility. One possibility to achieve multiunit tablets is to 
compress pellets. Micro tablets offer an alternative to pellets as they lead to dosage 
forms with smooth regular surface of equal dimensions and uniform weight. Micro 
tablets are very suitable for coating in order to sustain the drug release but the coating 
film has to withstand the applied compaction pressure while tableting into multiunit 
tablets. The tableting of matrix-type micro tablets was proposed as alternative for the 
production of sustained-release multiunit dosage forms.  
 
The aim of this work was to produce multiunit tablets containing a high percentage of 
single units and to ensure uniformity of weight and content of single units per tablet 
under pilot plant conditions. The influence of the size of the single unit and the 
influence of the composition of the filler on the tablet mass and content uniformity 
were investigated. For this purpose, four sizes of pellets ranging from 355 µm to 1700 
µm and two types of 2 mm-micro tablets were compressed with Avicel PH 101 or a 
mixture of Avicel PH 101/Avicel PH 200 as a filler, Kollidon CL as a disintegrant, 
Aerosil 200 as a glidant and magnesium stearate as a lubricant. StarLac containing 
placebo micro tablets were used for the weight uniformity study, and theophylline 
micro tablets based on an Eudragit RS PO matrix were used for the content uniformity 
and release studies. A content of 60 % (w/w) single units was established for the pilot 
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plant experiments. Batches of 30 kg of single units and excipients were mixed in a 
gyro-wheel mixer for 20 min at 40 rpm. The mixtures were compressed on an 
instrumented rotary tablet press Korsch Pharma 230/17. The parameters of the tablet 
press were:  
- speed: 50 rpm 
- compaction force: 150 MPa 
- tableting time: 1 hour 
- feeder type: gravity feeder 
- punches: 8 pairs of 13 mm round flat-faced punches of type B 
 
 
Influence of single unit size on the tablet weight and uniformity of single units per 
tablet 
The production of non-segregating mixtures of single units and excipients has to be 
guaranteed in order to obtain tablets conforming to the pharmacopoeial requirements 
with respect to weight uniformity and presenting uniformity of single units within one 
tablet. The tableting within 1 hour of single units varying between 355 µm and 2000 
µm with Avicel PH 101 as a filler led to higher weight variations when using units 
above 355-425 µm. The coarser the pellets, the greater were the weight variations and 
the percentage of rejected tablets. However, the weight variations of the multiunit 
tablets consisting of micro tablets were similar to those of medium sized pellets. The 
percentage by weight of micro tablets per tablet remained constant during the tableting 
process indicating that the weight variations were attributed to irregularities during 
filling of the die. 
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Flowability studies and tableting of flow-optimised formulations 
The flow properties of the different 30 kg- batches were investigated according to DIN 
53916 using a Pfrengle’s funnel and a self-constructed conveyor belt. The self-
constructed conveyor belt has demonstrated to be more adequate and reproducible to 
study flow properties. Moreover, more significant differences between the different 
mixtures were pointed out with the conveyor belt than with the Pfrengle’s funnel. A 
mixture consisting of Ludipress was found to have the fastest flow rate, followed by 
mixtures of pellets in a range of 850-1000 µm, pellets of 355-450 µm, pellets of 1180-
1400 µm and finally pellets of 1400-1700 µm. In regards to the mixture, it was shown 
that a mixture of 60 % (w/w) small pellets contains much more pellets than a mixture 
containing 60 % (w/w) micro tablets. Thus, the volume of one unit: pellet (or micro 
tablet)/excipient is much bigger for mixtures consisting of micro tablets than for 
mixtures consisting of small pellets. Consequently, the poor flow properties of the 
excipient are becoming dominant in mixtures of coarse pellets or micro tablets. 
In order to reduce the negative influence of Avicel PH 101 on the flow properties of 
the batches, a mixture of Avicel PH 101/Avicel PH 200 in a proportion of 30:70 % 
(w/w) was mixed with pellets in a range of 1400-1700 µm and with micro tablets. The 
flow rates were increased and the tablet weight variations as well as the percentage of 
rejected tablets were drastically reduced. 
 
 
Properties of tablets prepared from pellets and micro tablets 
Crushing strength and friability 
The crushing strength and the friability of the multiunit tablets compressed with Avicel 
PH 101 as a filler were dependent on the size of the single units. The bigger the single 
unit, the lower was the crushing strength and the higher the friability. The addition of 
the coarse Avicel PH 200 to the mixture consisting of pellets in a range of 1400-1700 
µm led to tablets with a lower crushing strength and a higher friability. However, the 
composition of the filler had no influence on the crushing strength and friability of 
tablets produced from micro tablets. In case of the micro tablets, the crushing strength 
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is conferred by the micro tablets themselves and less by the number of particles, which 
is the case for the multiunit tablets consisting of pellets.  
 
Disintegration time 
The disintegration time of the multiunit tablets compressed with Avicel PH 101 was 
dependent on the single units size. The coarser the pellets, the faster were the 
disintegration times. However, the disintegration time of all the mixtures was lower 
than 15 min. The disintegration time of tablets made of pellets in a range of 1400-1700 
µm was reduced from 31 s to 20 s when using the mixture Avicel PH 101/Avicel PH 
200 [30:70] as a filler. However, the composition of the filler had no influence on the 
disintegration time of tablets prepared from micro tablets. 
 
Dissolution 
The release of theophylline from micro tablets based on an Eudragit RS PO matrix 
within an 8 hr-period has shown to be independent on the dissolution medium. The 
major advantage of the matrix micro tablets resulted in the fact that the compression 
process did not influence the theophylline release of the micro tablets, as the 
theophylline release profiles were similar before and after compression.  
 
 
In order to produce multiunit tablets containing 60 % (w/w) of single units (pellets or 
micro tablets) under pilot plant conditions and to ensure uniformity of weight and 
content as well as satisfying physical properties, two formulations were developed 
depending on the single unit size.  
For pellets in a range of 355-425 µm, the tableting mixture was: 
• 60 % pellets 
• 35.2 % Avicel PH 101, as a filler 
• 4 % Kollidon CL, as a disintegrant 
7 CONCLUSION  93 
• 0.3 % Aerosil, as a glidant and 
• 0.5 % magnesium stearate, as a lubricant 
 
For pellets in a range from 850 µm to 1700 µm and 2 mm-micro tablets, it was 
necessary to add a coarser microcrystalline cellulose Avicel PH 200 to Avicel PH 101 
in order to compensate the negative effect of the fine filler on the flow properties of 
the tableting mixtures. The formulation was then:  
• 60 % single units, coarse pellets or micro tablets 
• 35.2 % Avicel PH 101/Avicel PH 200 in a proportion of 30:70 % (w/w) 
• 4 % Kollidon CL 
• 0.3 % Aerosil 
• 0.5 % magnesium stearate 
 
This work has demonstrated that the size of single units had a major effect on the 
uniformity of multiunit tablets under pilot plant conditions. Although mixtures 
showing a great difference between the size of the single units and the excipients are 
expected to be unstable and to segregate, it was observed that the content of micro 
tablets per tablet remained constant. Actually, the tablet weight variations were related 
to the flow properties of the tablet mass. The optimisation of the composition of the 
filler/binder in order to improve the flow properties of the mixtures led to multiunit 
tablets conforming to the pharmacopoeial requirements with respect to weight 
uniformity. 
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CHAPTER 9 
APPENDIX 
9.1 Index of suppliers 
Abbott GmbH & Co. KG (formerly Knoll AG), Knollstrasse, D-67061 Ludwigshafen  
W. A. Bachofen Maschinenfabrik, Utengasse 15/17, CH-4002 Basel 
BASF AG, Carl-Bosch-Str. 38, D-68056 Ludwigshafen 
Bärlocher GmbH, Riesstr. 16, D-80992 München 
Beckman Instruments Inc., Frankfurter Ring 115, D-80807 München 
Degussa-Hüls AG, Postfach 11 05 33, D-60314 Frankfurt/Main 
Engelsmann AG, Frankenthaler Str. 137-141, D-67059 Ludwigshafen 
Eppendorf AG, Barkhausenweg 1, D-22331 Hamburg 
Erweka GmbH, Ottostr. 20-22, D-63150 Heusenstamm 
Dr. F. Faulhaber GmbH & Co., Postfach 1146, D-71094 Schönaich 
Fluka Chemie AG, Industriestr. 25, CH-9470 Buchs 
FMC Corp. / Lehmann & Voss & Co. (see Lehmann & Voss & Co.) 
Glatt GmbH, Postfach 42, D-79589 Binzen 
Hanns G. Werner GmbH & Co., Hafenstrasse 9, D-25436 Tornesch 
Hottinger Baldwin Messtechnik GmbH, Im Tiefen See 45, D-64293 Darmstadt 
Janke & Kunkel, Postfach 12 63, D-79217 Staufen 
Kilian & Co. GmbH, Emdener Str. 10, D-50735 Köln 
Kistler Instruments GmbH, Eulachstr. 22, CH-8408 Winterthur 
Korsch Pressen GmbH, Breitenbachstr. 1, D-13509 Berlin 
Kuhnke GmbH, Lütjenburger Straße 101, D-23714 Malente 
Lehmann & Voss & Co., Postfach 30 34 24, D-20311 Hamburg 
Malvern Instruments GmbH, Rigipsstr. 19, D-71083 Herrenberg 
Meggle GmbH, Megglestr. 6-12, D-83512 Wasserburg 
Mettler Toledo GmbH, Ockerweg 3, D-35396 Gießen 
Microcal Software, Inc., Northampton, MA 01060 USA  
Microsoft GmbH, Edisonstr. 1, D-85716 Unterschleißheim 
Mitutoyo Messgeräte GmbH, Borsigstr. 8-10, D-41469 Neuss 
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NP Pharm S. A, 54 bis route de Paris, F-78550 Bazainville 
Perkin-Elmer GmbH, Postfach 10 11, D-88662 Überlingen 
Pharmatest Apparatebau, Postfach 11 50, D-63512 Hainburg 
Reiff-Technische Produkte GmbH, Tübinger Str. 2-6, D-72762 Reutlingen 
Röhm GmbH & Co. KG, Kirschenallee 1, D-64275 Darmstadt 
Ritter Pharma-Technik GmbH, Neumann-Reichardt Str. 36-387, D-22041 Hamburg 
Sartorius AG, Weender Landstr. 94-108, D-37075 Göttingen 
Dr. K. Schleuniger, Schöngrünstr. 27, CH-4501 Solothurn 
Servolift GmbH, Albert-Einstein-Str. 9, D-77656 Offenburg 
Sotax AG, Binningerstr. 106, CH-4123 Allschwill 
Sympatec GmbH, Burgstätter Str. 6, D-38678 Clausthal-Zellerfeld 
VCH Verlagsgesellschaft, Boschstr. 12, D-69469 Weinheim 
Watson-Marlow Ltd., Falmouth, TR 11 4RU, UK-Cornwall 
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9.2 Calibration data of the rotary tablet press Korsch Pharma 230/17 
 
Table 9.1 Raw data of the static calibration of Korsch Pharma 230/17 
Reference signal [kN] Upper punch signal [V] Reference signal [kN] 
 Lower punch signal 
[V] 
25.7690 3.4063 25.9192 6.2487 
25.7637 3.3353 25.8460 6.2982 
25.6923 3.4043 25.8566 6.2488 
25.7562 3.3302 25.8285 6.2906 
25.6795 3.3965 25.8522 6.2446 
25.7342 3.3325 25.8144 6.2923 
20.2110 2.5853 20.4981 4.9866 
20.1257 2.6328 20.5513 4.9443 
20.2237 2.5729 20.5048 4.9875 
20.1430 2.6339 20.5353 4.9494 
20.2046 2.5745 20.4949 4.9861 
20.1438 2.6339 20.5347 4.9442 
14.9870 1.9112 14.8353 3.6041 
15.0529 1.8654 14.8768 3.5675 
14.9955 1.9132 14.8434 3.5972 
15.0334 1.8635 14.8776 3.5720 
14.9827 1.9112 14.8323 3.6062 
15.0602 1.8659 14.8638 3.5762 
10.6268 1.2559 10.4436 2.5476 
10.5907 1.2913 10.4702 2.5141 
10.6271 1.2585 10.4532 2.5364 
10.6108 1.2949 10.4835 2.5066 
10.6287 1.2603 10.4553 2.5429 
10.6060 1.2923 10.4765 2.5105 
4.8989 0.4783 5.1313 1.2060 
4.8735 0.4935 5.0935 1.2513 
4.8926 0.4783 5.1374 1.2085 
4.8629 0.4933 5.1093 1.2472 
4.9145 0.4812 5.1409 1.2103 
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4.8763 0.4941 5.1160 1.2485 
2.0128 0.1210 2.0832 0.4541 
2.0312 0.1052 2.1109 0.4436 
2.0049 0.1214 2.0975 0.4570 
2.0241 0.1057 2.1192 0.4434 
2.0106 0.1216 2.1003 0.4614 
2.0380 0.1036 2.1266 0.4451 
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